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Selenoprotein   N1   (SEPN1)   is   a   member   of   the   selenocysteine-­‐containing   protein  
family,  that  is  localised  in  the  endoplasmic  reticulum  (ER)  and  ubiquitously  expressed  
throughout  the  body.    
Mutations  in  the  human  SEPN1  gene  were  identified  as  the  genetic  cause  of  a  muscle  
disease   referred   as   SEPN1-­‐related  myopathy   (SEPN1-­‐RM),   in  which   the  main   clinical  
features  are  axial  weakness,   scoliosis,   a  variable  degree  of   spinal   rigidity,   respiratory  
failure  and  insulin  resistance.    
The  selective  muscle  phenotype  of  the  human  SEPN1  loss  of  function,  the  redox  nature  
of   SEPN1,   and   the   fact   that   SEPN1-­‐depleted   cells   show   oxidative   stress   support   the  
idea  that  SEPN1  may  be  involved  in  protecting  muscle  ER  redox  homeostasis.  
Ascorbic  acid  is  an  important  antioxidant  that  is  localized  in  the  cytoplasm  and  in  the  
endoplasmic   reticulum   lumen,   since   it   is   a   cofactor   needed   in   the   folding   of   pro-­‐
collagen.   Malnutrition   characterized   by   low   intake   of   ascorbic   acid   affects   skeletal  
muscles,  in  terms  of  fatigue  and  myalgia.      
Thus,   both   ascorbic   acid   and   SEPN1   deficiency   bring   to   the   development   of   a  
myopathic  condition,  which  can  be  explained  by  the  fact  that  the  two  molecules  have  
overlapping  functions  and  intracellular  localization.  
To   test   the   hypothesis   that   the   anti-­‐oxidant   vitamin   ascorbic   acid   protects   SEPN1  
knock   out   (KO)   muscles   from   the   consequences   of   SEPN1   loss   of   function   we  
developed  a  mouse  model  mutant  of   SEPN1,  which   is  also  dependent  on  exogenous  
ascorbic   acid.  Our   findings   showed   that   a   limited   intake   of   ascorbic   acid   triggers   ER  
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stress   and   exacerbates   SEPN1-­‐related  myopathic   phenotype   suggesting   a   protective  
role   of   the   ascorbic   acid   in   SEPN1   KO  muscle.  We   also   found   that   the   highly   active  
diaphragm  muscle  shows   impaired  force  production  and  ER  stress   in  SEPN1  KO  mice  
and   that   the   ablation   of   the   ER   stress   mediator   C/EBP   homologous   protein   (CHOP)  
prevents  diaphragm  dysfunction  and  attenuates  ER  stress  in  SEPN1  KO  mice.      
Lipotoxicity,  meaning  an  overload  of  fatty  acids,  is  among  the  conditions  able  to  trigger  
ER   stress.   By   feeding   SEPN1   KO   mice   with   a   high-­‐fat   diet,   we   observed   that   the  
myopathic  phenotype  is  not  only  restricted  to  the  diaphragm,  but  also  to  the  hind  limb  
muscles   of   SEPN1   KO   mice.   These   mice   developed   myopathic   features   that   were  
characterised  by  the  insurgence  of  ER  stress.    
These   findings   suggest   that   ER   stress   is   a   novel   pathogenic   mechanism   underlying  
SEPN1-­‐RM   and   therefore   reveal   a   therapeutic   target   for   this   disease,   for   which   no  












In  this  thesis  it  is  reported  the  work  that  I’ve  carried  out  during  my  PhD  program  from  
October  2015   to  October   2019   under   the   supervision  and  direction   of  Dr.   Ester   Zito  
(director   of   the   studies)   and   Prof.   David   Ron   and   Stefan   Marciniak   (external  
supervisors)  at  the  Istituto  di  Ricerche  Farmacologiche  Mario  Negri  IRCCS.  
  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  





This  PhD  research  project  has  not  been  submitted  in  whole  or  in  part  for  a  degree  or  
diploma   or   other   qualification   to   any   other   university.   The   experimental   work  
described  herein  was  performed  by  myself,  Diego  Pozzer,  and  also  includes  some  work  
carried  out  in  collaboration  with  the  members  of  the  laboratory  of  Signal  Transduction  
and  with:  
  
-­‐    Dr.  William  Invernizzi,  head  of  “Neurochemistry  and  behaviour  Lab”  at  the  Istituto  di  
Ricerche  Farmacologiche  Mario  Negri  IRCCS  in  Milan,  who  is  an  expert  in  ascorbic  acid  
measurements.    
-­‐      Prof.   Bert   Blaaw,   Associate   Professor   at   the   Università   degli   Studi   di   Padova   and  
group   leader  at  VIMM  (Venetian   Institute  of  Molecular  Medicine),  who   took  care  of  
the  measurements  of  the  muscle  force.  	  	  	  	  	  	  	  	  







First  of  all,  I  would  like  to  thank  my  supervisor  Dr.  Ester  Zito.  In  her  lab  I   learned  the  
traits   that   a   good   researcher   should   develop,   such   as   the   importance   of   creating   a  
proper  hypothesis  with  clear  goals  and  the  need  of  planning  in  details  every  aspect  of  
an  experiment.    
Special   thanks   to   my   external   supervisors,   Dr.   David   Ron   and   Dr.   Stefan  Marciniak,  
who,  throughout  the  four  years  of  PhD,  gave  me  opinions  and  support.  
Dr.  William  Invernizzi  and  Prof.  Bert  Blaauw  have  been  extremely  kind  to  me,  sharing  
their   knowledge   and   expertise   in   the   HPLC   and   muscle   force   measurements  
respectively.  
Heartfelt  gratitude  to  my  previous  and  present  lab  mates,  with  honourable  mentions  
to  Alex,  Ersilia  and  Simona,  and  to  all  of  the  friends  that  I  made  here  in  the  Institute.  
I  understood  that  a  positive  working  environment   is  crucial   to  sustain  the  challenges  








     
6  
  




2DG  =  H3-­‐2-­‐deoxyglucose  
ASC  and  AA  =  Ascorbic  Acid  
ATF6  =  Activating  Transcription  Factor  6  
ATP  =  Adenosine  TrisPhosphate  
BIP  =  Binding  Immunoglobulin  Protein    
CHOP  =  C/EBP  homologous  protein    
CFTD  =  congenital  fiber  type  disproportion  
CHOP  =  C/EBP  homologous  protein  
CRU  =  Calcium  Release  Unit    
DHA  =  DeHydroAscorbic  acid  
DHPR  =  DiHydroPyridine  Receptor  
EC-­‐Coupling  =  Excitation-­‐Contraction  coupling    
ECM  =  Extra-­‐Cellular  Matrix  
eIF2-­‐α  =  eukaryotic  Initiation  Factor  2-­‐alpha  
ER  =  Endoplasmic  Reticulum  
ERAD  =  ER-­‐Associated  protein  Degradation  
ERO1  =  ER  Oxidoreductin  1  
ERp44  =  Endoplasmic  Reticulum  resident  protein  44    
FADH  =  Flavin  Adenine  Dinucleotide  (reduced)  
GADD34  =  Growth  Arrest  and  DNA  Damage-­‐inducible  protein  34  
GLUT  =  GLUcose  Transporter  
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GPX  =  Glutathione  PeroXidase  
GSH  =  Glutathione  
HFD  =  High-­‐Fat  Diet  
IMM  =  Inner  Mitochondrial  Membrane  
IP3R1  =  Inositol  1,4,5-­‐trisphosphate  Receptor  isoform  1  
IRE1  =  Inositol-­‐Requiring  Enzyme  1    
JSR  =  Junctional  Sarcoplasmic  Reticulum    
KD  =  Keshan  Disease  
GULO  =  l-­‐GULOno-­‐lactone  oxidase    
MB-­‐DRM  =  Desmin-­‐Related  Myopathy  with  Mallory  Body-­‐like  inclusions  
MmD  =  Multi-­‐minicore  Disease  
NADH  =  Nicotinamide  Adenine  Dinucleotide  (reduced)    
NADPH  =  Nicotinamide  Adenine  Dinucleotide  Phosphate  (reduced)  
NOX4  =  NADPH  Oxidase  4  
OMM  =  Outer  Mitochondrial  Membrane  
OxPhos  =  Oxidative  Phosphorylation  
PDI  =  Protein  Disulfide  Isomerase  
PERK  =  Protein  kinase  r-­‐like  ER  Kinase  
PP1  =  Protein  Phosphatase  1  
PRDX4  =  PeRoxireDoXin-­‐4  
ROS  =  Reactive  Oxygen  Species  
RyR1  =  Ryanodine  Receptor  1  
SECIS  =  SElenoCysteine  Insertion  Sequence  
SelK  =  Selenoprotein  K  
SEPN1-­‐RM  =  SEPN1-­‐Related  Myopathy  
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SERCA2  =  Sarco-­‐Endoplasmic  Reticulum  Calcium  ATPase  2  
SR  =  Sarcoplasmic  Reticulum  
SRE  =  Selenocysteine  codon  Redefinition  Element  
SVCT  =  Sodium  dependent  Vitamin  C  Transporter  
Trx  =  ThioRedoXin    
TrxRs  =  Thioredoxin  Reductases    
T-­‐tubule  =  Transverse  tubule    
UPR  =  Unfolded  Protein  Response  
WMD  =  White  Muscle  Disease  
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1.1.1	  -­‐‑	  An	  introduction	  to	  selenium	  
Selenium  is  a  chemical  metalloid  element,  discovered  in  1817  by  Jöns  Jacob  Berzelius,  
towards   which   the   interest   has   grown   over   the   years,   due   to   some   contradictory  
conclusions  regarding  its  impact  on  human  health.    
The   main   source   of   selenium   comes   from   food,   particularly   cereals,   meat,   fish   and  
dairy  products,  although  it  is  believed  that  the  worldwide  difference  in  the  amount  of  
selenium   among   living   beings   reflects   the   levels   of   selenium   in   the   soils   (Rayman,  
2008)  (Figure  1).    
The  recommended  amount  of  daily  intake  of  selenium  is  53  µg  per  day  for  women  and  
60  µg  per  day  for  men  (Rayman,  2004)  but  up  to  800  µg  per  day  of  selenium  showed  
no  adverse  effects  (Weekley  and  Harris,  2013).    
Selenium   is   incorporated   in   mammals   primarily   as   selenocysteine,   an   amino   acid  
incorporated  in  the  selenoproteins  (Figure  2).  





















Figure  2    -­‐  Organic  forms  of  selenium  (Rocha  et  al.,  2016).  
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1.1.2	  –	  Selenium	  and	  its	  correlation	  with	  human	  pathologies	  
Many  evidences   suggest   that  deficiency  of   selenium   is   linked   to   the  onset  of   several  
human   diseases.   Among   these,   diseases   of   endocrine   and   cardiovascular   system  
together  with  cancer  are  those  more  connected  with  a  selenium  deficiency  (Figure  3).  
  
  Figure   3   -­‐   Number   of  
publications   regarding   the  
connection   between  
selenium   dis-­‐levels   and  





1.1.3	  –	  Emblematic	  example	  of	  a	  disease	  due	  to	  low	  intake	  of	  selenium:	  Keshan	  
disease	  
Keshan  disease  (KD)  is  an  endemic  cardiomyopathy  characterised  by  multifocal  cardiac  
necrosis  that  is  endemic  in  an  area  of  China  known  as  Keshan  (from  which  the  name  of  
the  disease).     This  disease  is  caused  by  a  dietary  deficiency  of  selenium  whose  levels  
are   particularly   low   in   the   soil   of   Keshan.  Quantitative   analysis   of   selenium   levels   in  
human  samples  (scalp  hair,  blood,  urine)  and  locally  grown  cereals  have  shown  a  direct  
correlation   between   low   levels   of   selenium   in   the   biological   samples   of   affected  
individuals  and  low  levels  of  selenium  in  soil  (Chen  et  al.,  1980).  For  example,  the  hair  
levels  of  selenium  in  KD  patients  was  under  0.12  ppm  that  is  almost  half  of  the  levels  of  
healthy  populations  (that  is  around  0.20  ppm)  (Ge  et  al.,  1983).  
Oral   supplementation   with   sodium   selenite   resulted   in   prevention   of   the   disease,  
highlighting  that  low  levels  of  selenium  is  the  primary  cause  of  KD  (Chen  et  al.,  1980).  
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Deficiency   of   selenium  exerts   its   pathological  effects   through   the   impairment   of   the  
function   of   selenoproteins.   Indeed,   not   only   the   amount   of   selenium   in   blood   and  
urine  was  lower  in  KD  patients  but  also  the  levels  of  glutathion  peroxidases  (GPXs),  the  
most  important  class  of  selenoproteins,  were  decreased  (Levander  and  Beck,  1997).  
The   incidence   of   KD   was   variable   among   the   different   seasons   of   the   year   and  
importantly  not  all  of   the  selenium  deficient   inhabitants  became   ill  suggesting  that  a  
second  factor  was  necessary  to  develop  KD  (Yang,  1985).  In  fact,  viral  infections  from  
Coxsackie   virus   B4,   a   single-­‐RNA   stranded   pathogenic   enterovirus   that   causes  
myocarditis,   was   found   in   KD   victims   (Levander   and   Beck,   1997).   In   vivo   studies   on  
animal  models  confirmed  the  implication  of  Coxsackievirus  in  the  development  of  the  
heart  damage  of  KD  patients:  selenium-­‐deficient  mice  infected  with  Coxsackie  virus  B4    
developed   more   severe   heart   problems   than   the   control   group   fed   a   standard  
selenium  diet  and  infected  with  the  virus  (Bai,  1980).  
In  addition,  a  deficiency  of  the  anti-­‐oxidant  vitamin  E  had  very  similar  effects  on  mice  
infected  with   the  Coxsackie  virus  B3/20   (a  myocarditic   strain  of   the  aforementioned  
virus),  suggesting  a  potential  overlapping  function  of  selenium  and  vitamin  E  (Lippman  
et  al.,  2009)  (Hoekstra,  1975).  
  
1.1.4	  –	  Selenium	  and	  myopathies	  in	  animals	  
The   correlation   between   the   amount   of   selenium   and  muscle   pathologies   has   been  
known  since  the  middle  of  the  last  century.  
Livestock   that   are   raised   in   selenium-­‐poor   soils   develop   the   “white  muscle   disease”  
(WMD),  a  muscle  pathology  characterised  by  progressive  muscular  weakness  affecting  
mainly  highly  active  muscles,  such  as  diaphragm,  masticatory  muscles  and  myocardium  
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(Delesalle   et   al.,   2017).   Muscles   biopsies   from  WMD-­‐affected   animals   present   pale  
striations   (Figure   4   and   5),   hence   the   name   of   the   disease,   and   blood   serum   from  
affected  animals  contains  low   levels  of  GPX.  This  disease   is  caused  by  a  deficiency  of  
selenium  and/or  vitamin  E,  for  this  it  is  classified  as  a  “nutritional  myopathy”  and  the  
affected  animals  can  be  treated  by  adding  supplements  of  sodium  selenite  and  vitamin  
E  to  the  diet.  
As   for   KD,   WMD   is   also   due   to   a   simultaneous   deficiency   of   vitamin   E,   which   has  
antioxidant   functions,   and   selenium   indicating   that   the   accumulation   of   oxygen  
radicals  in  the  muscle  may  be  the  pathogenic  cause  of  the  disease  (Finno  and  Valberg,  
2012)  (Delesalle  et  al.,  2017).  
  
  
Figure  4  -­‐  WMD  muscle  (on  the  right)  have  

















Figure  5  -­‐  H&E  staining  of  a  skeletal  muscle  from  a  WMD  animal.  a)  Transverse  section  
showing  multifocal  mineralization  (black  arrows)  b)  Longitudinal  section  depicting  the  
fragmentation   of   the   skeletal   muscle   and   macrophages   infiltration   (arrowhead)    




1.1.5	  –	  Selenium	  and	  myopathies	  in	  human	  
Another   interesting   indication   of   the   correlation   between   selenium   deficiency   and  
myopathy  comes  from  the  observation  of  human  patients  under  prolonged  parenteral  
nutrition.  In  many  cases,  in  fact,  the  muscle  weakness  of  these  patients  was  associated  
with  a  severe  selenium  deficiency  in  blood.  Twenty-­‐two  post-­‐operative  patients  under  
total  parenteral  nutrition  from  10  to  40  days  were  diagnosed  with  a  clinical  selenium  
responsive  syndrome  characterised  by  severe  muscle  pain    (Abrams  et  al.,  1992).  Low  
levels  of  selenium  have  been  also  connected  to  the  sarcopenia  (loss  of  muscle  mass)  as  
a   consequence   of   aging.   The   “in   CHIANTI”   study   (“Invecchiare   in   Chianti”,   meaning  
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Aging  in  Chianti,  an  area  of  Tuscany,  Italy)  tried  to  shed  some  light  on  the  mechanisms  
underlying  aging,  hypothesizing  that  poor  muscle  strength   in  the  elderly  is  caused  by  
low  selenium  levels  in  plasma  (Lauretani  et  al.,  2007).  In  this  study  the  data  obtained  
from   a   cohort   of   1155   patients   of   equal   or   more   than   65   years   old   highlighted   a  
connection  between  low  selenium  levels  and  poor  grip  strength.  However  a  causative  
effect   between   low   selenium   level   and   muscle   weakness   was   missing   in   this   study  
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1.2.1	  –	  History	  of	  selenoproteins	  
Selenocysteine   (Figure   6)   was   recognized,   after   a   long   time,   as   the   21st   amino   acid  
(Chambers  et  al.,  1986;  Zinoni  et  al.,  1986)  since  It’s  encoded  by  an  UGA  codon,  which  
is  usually  one  of  the  three  stop  codons  (Kryukov  et  al.,  2003).  
Figure   6   -­‐   Chemical   structure   of   the  





Selenocysteine   is   incorporated   into   proteins  as  a   result  of  a  genetic   code  expansion,  
because  the  translation  of  selenoproteins  involves  the  decoding  of  a  UGA  codon  that  
would   otherwise   be   a   termination   codon.   The   UGA   codon   is   decoded   by   means   of  
species-­‐specific   mechanisms   guided   by   a   secondary   structure   in   the   3'-­‐UTR   of  
selenoprotein  mRNA   and   requiring   the   involvement   of   a   stem   loop   structure   of   the  
selenocysteine   insertion   sequence   (SECIS)   (Figure   7)(Lescure   et   al.,   2009)   and   other  
factors   such   as   a   selenocysteine-­‐specific   elongation   factor,   selenophosphatase  
synthetase  and  a  SECIS  binding  protein  (Figure  8)  (Kryukov  et  al.,  2003).    









Figure  8  –  Graphical  representation  of  the  SECIS  element  at  the  3’  untranslated  region  
of   the   mRNA,   together   with   other   six   elements   which   regulate   the   selenocysteine  
incorporation:   Sec-­‐specific   elongation   factor   (eEFSec),   selenocysteine-­‐insertion  
sequence   binding   protein   2   (SBP2),   nuclease   sensitive   element-­‐binding   protein   1  
(NSEP1),  SecP43,  DNA-­‐binding  protein  B  and  nucleolin  (Loscalzo,  2014).  
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The  importance  of  these  factors  in  the  selenoprotein  synthesis  is  demonstrated  by  the  
fact   that      genetic   mutations   in   selenocysteine-­‐insertion   sequence   binding   protein  
(SBP2),  one  of   the  elements  of   the  SECIS   complex,   give   rise   to   loss  of   function  of  all  
selenoproteins  and  a  multisystemic  syndrome  characterised  by  growth  retardation  and  
abnormal   thyroid   function   (Dumitrescu   et   al.,   2010).   Compromised   bones,   inner   ear  
and  muscles  are  other  clinical  features  of  this  pathology  (Fradejas-­‐Villar,  2018).  
The   selenol   group   (-­‐SeH,   also   called   selenohydryl   group   or   SeC),   found   in  
selenocysteinyl  residue  of  selenoproteins,  is  an  analogue  of  the  thiol  group  (-­‐SH,  also  
called   sulfhydryl   group)   of   cysteine   with   a   higher   nucleophilicity   (Johansson   et   al.,  
2005)  (Rocha  et  al.,  2016)  (Figure  9  and  10).      
  
  
Figure   9   -­‐   Chemical   structure   of  





Figure   10   –   Graphical  
representation   of   the   nucleophilic  
attack   of   the   cysteine   and  
selenocysteine   on   an   oxidized  
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1.2.2	  –	  Mammalians	  selenoproteins	  
The   human   selenoproteome   consists   of   25   selenoproteins   containing   at   least   one  
selenocysteine   which   is   involved   in   the   biological   function   of   the   selenoprotein  
(Addinsall   et   al.,   2018)   (Shchedrina   et   al.,   2010).   In   2016,   a   new   nomenclature  was  
suggested   for   the   selenoproteins   (Table1):   the   root   symbol   SELENO   followed   by   a  
letter  identify  selenoproteins  whose  function  is  still  not  known  whereas  selenoproteins  
with  a  known  function  will  continue  to  be  identified  with  the  old  name  (Gladyshev  et  
al.,   2016).   For   the  purpose  of   this   thesis,   Selenoprotein  N  will  be   indicated  with   the  
classical  symbol  SEPN1.  
Symbol   Name   Synonyms   Subcellular  location  




SELENOH   Selenoprotein  H   SELH,  C11orf31   Nucleus  
SELENOI   Selenoprotein  I   SELI,  EPT1   Unknown  
SELENOK   Selenoprotein  K   SELK  
ER  and  plasma  
membrane  
SELENOM   Selenoprotein  M   SELM,  SEPM   ER  lumen  
SELENON  
(SEPN1)   Selenoprotein  N   SEPN1,  SELENON   ER  membrane  
SELENOO   Selenoprotein  O   SELO   Unknown  
SELENOP   Selenoprotein  P  
SEPP1,  SeP,  SELP,  
SEPP  
Secreted  
SELENOS   Selenoprotein  S   SELS,  SEPS1,  VIMP  
ER  and  plasma  
membrane  
SELENOT   Selenoprotein  T   SELT   ER  membrane  
SELENOV   Selenoprotein  V   SELV   Unknown  
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SELENOW   Selenoprotein  W   SELW,  SEPW1   Cytosol  
TXNRD1   Thioredoxin  reductase  1   TR1,  TRXR1   Cytosol,  nucleus  
TXNRD2   Thioredoxin  reductase  2   TRXR2,  TR3,   Mitochondria  
TXNRD3  
Thioredoxin-­‐glutathion  
reductase                 TGR,  TRXR3,  TR2	  
Cytosol  




GPX2   Glutathione  peroxidase  2   GSHPX-­‐G1   Cytosol  
































synthetase  2   SPS2  
Cytosol  
  
Table   1   -­‐   New   nomenclature   of   the   25   selenoproteins   (Gladyshev   et   al.,   2016)  
(Shchedrina  et  al.,  2010)  together  with  their  subcellular  localization.    
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GPXs   are   the   first   identified   selenoproteins   in  mammals   in   1970’s   (Fohe   and   Gzler,  
1973).   These   enzymes   are   involved   in   the   defence   of   the   cell   from   the   oxidative  
damage   of   H2O2   or   organic   hydroperoxide,   which   are   reduced   to   water   or  
corresponding  alcohols  by  using  glutathione   (GSH)  as   source   of   reducing  equivalents  
(H2O2  +  2GSH  →  2H2O  +  GS-­‐SG).  
Another   important   class   of   selenoproteins   is   represented   by   the   Thioredoxin  
reductases   (TrxRs),   whose   function   is   to   catalyse   the   reduction   of   thioredoxin   (Trx).  
Together  with  Trx  and  nicotinamide  adenine  dinucleotide  phosphate  (NADPH),  TrxR  is  
part  of  the  thioredoxin  system  that  reduces  disulfide  bonds  in  proteins  (Shchedrina  et  
al.,   2010).   Briefly,   electrons   flow   from  NADPH   to   thioredoxin   reductase   and   then   to  
thioredoxin  and  finally  reduce  a  disulphide  bond  in  a  thiol  of  a  proteinaceous  substrate  
(Holmgren   A,   Lu   J   2010).   The   enzymatic   mechanism   of   TrxR   relies   on   an   electron  
transfer  relay  with  Trx:  the  nucleophilic  selenolate  anion  of  the  selenocysteine  in  TrxR  
attacks  a  cysteine  on  Trx  to  form  a  selenenyl-­‐sulfide  intermediate  that  is  later  resolved  
by  the  resolving  cysteine  in  the  catalytic  site  of  TrxR  (Lu  et  al.,  2009)  (Figure  11).    
  
Figure  11  -­‐  Catalytic  mechanism  of  
the   thioredoxin   system.  A  disulfide  
bridge   in   Trx   is   reduced   by  
electrons   donated   by   TrxR.  
Reduced-­‐Trx   transfers   electrons   to  
a   disulphide   bond   of   the   final  
substrate   that   is   reduced   in   a   free  
thiol  (image  courtesy  of  Wikipedia).      
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Iodothyronine   deiodinases   (or   selenodeiodinases)   are   integral   membrane  
selenoproteins   (DIO1   and   DIO3   are   located   in   the   plasma   membrane,   DIO2   in   the  
endoplasmic  reticulum).     DIO2  activates  the  thyroid  hormone,  while  DIO3   inactivates  
it.  DIO1  is  able  to  activate  and  inactivate  thyroid  hormone  depending  on  which  iodine  
is  removed  from  the  iodothyronine  molecule  (Marsili  et  al.,  2016).  
Since   both   hypo-­‐   and   hyperthyroidism   impair  muscle   function   (Dentice   et   al.,   2010)  
(Dentice  et  al.,  2014),  Iodothyronine  deiodinases  have  been  studied  to  evaluate  their  
effect  on  muscle.  DIO2  and  DIO3  are  important  to  regulate  satellite  cells  differentiation  
during  muscle  regeneration  after  an  injury  (Marsili  et  al.,  2016).  
Selenoprotein  W   (SELENOW)   is   the   smallest   selenoprotein   containing   a   Cys-­‐X-­‐X-­‐SeC  
motif   and   is  mostly   present   in   skeletal  muscle   and   brain   of  mammals   (Loflin   et   al.,  
2006).  SELENOW  is  required  for  the  differentiation  of  myoblasts  in  myotubes  (Noh  et  
al.,  2010)  and  its     loss  is  associated  with    KD  and    WMD  (see  chapter  1.1.3  and  1.1.4)  
(Papp  et  al.,  2010;  Whanger,  2000).    
Selenoprotein  S  is  one  of  the  seven  ER  resident  selenoproteins  (Figure  12)  and  is  highly  
expressed   in   skeletal   muscle.   The   impairment   of   the   muscle   strength   of   SELENOS  
knock-­‐out   mice   suggests   an   important   role   of   SELENOS   in   the   muscle   contraction  
(Addinsall  et  al.,  2018).  
  
Selenoproteins  have  been  linked  to  ER  stress.    In  rat  cardiomyocytes,  overexpression  of  
selenoprotein   K   (SelK),   one   of   the   ER   resident   selenoproteins,   decreased   the  
production  of  ROS  (Lu  et  al.,  2006).  Thus,  SelK  plays  an  important  role  in  the  oxidative  
stress  provoked  by  accumulation  of  hydrogen  peroxide.    
Another  ER  selenoprotein,  SelS,  is  involved  in  the  regulation  of  ER  stress.  SelS  is  one  of  
the   component   of   the   endoplasmic   reticulum-­‐associated   degradation   (ERAD)  
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machinery  (Lilley  and  Ploegh,  2004),  which  is  devoted  to  the  transport  of  unfolded  and  
misfolded  proteins  to  the  cytosol,  for  further  degradation.  For  this  reason,  SelS  could  
be   crucial   to   limit   the   accumulation   of   proteins   inside   the   ER,   hence   to   avoid   the  
insurgence  of  ER  stress.  
  
  
Figure   12   -­‐   Schematic   representation   of   the  mammalian   ER   selenoproteins   and   their  
domains.     D2,  SelK,   SelS  and  SelN  contain   the   transmembrane   (TM)   region  at   the  N-­‐
terminal   (violet   box).   Thioredoxin-­‐like   fold   known   for   D2,   Sep15,   SelM   and   SelT   are  
indicated  (yellow  boxes).  Sec  (U)  location  is  depicted  in  red.  N-­‐terminal  signal  peptide  in  
Sep15  and  SelM  is  indicated  in  pink.  EF-­‐hand  motif  (blue  box)  in  SelN  (blue  box),  coiled-­‐
coil   domain   in   SelS   (light   grey   box),   ER   retention   signal   in   SelM   (grey   box),   UGGT-­‐
binding  domain  in  Sep15  (green  box)  and   Iduronidase  alpha-­‐L   (IDUA)-­‐like  sequence   in  
D2  (light  blue)  are  also  reported  (Shchedrina  et  al.,  2010).    
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1.3.1	  –	  Selenoprotein	  N	  (SEPN1):	  a	  general	  introduction	  
In   1999,   bioinformatics   analyses   in   search   for   SECIS   sequence   brought   SEPN1   to   the  
light  (Lescure  et  al.,  1999).  
SEPN1   gene   is   located   on   chromosome   1p35-­‐p36.   The   coding   sequence   is  
characterised   by   13   exons   and   the   selenocysteine   UGA   codon   is   on   the   exon   10  
(Moghadaszadeh   et   al.,   2001).   Two   alternatively   spliced   transcript   variants   encoding  
two  distinct  SEPN1  isoforms  have  been  found  but  the  shorter  transcript  is  predominant  
in   the  majority   of   cells   (Lin   et   al.,   2008;  Makałowski   et   al.,   1994;   Petit   et   al.,   2003;  
Schmid  and  Jelinek,  1982).  
Although   mutations   in   other   selenoproteins,   such   as   GPXs,   TrxRs   and   deiodinases,  
have   been   linked   to   different   types   of   disease,   SEPN1   was   the   first   identified  
selenoprotein   whose   mutations   are   associated   to   a   genetic   pathology,   referred   as  
“SEPN1-­‐related  myopathy”  (SEPN1-­‐RM).    
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1.3.2	  –	  SEPN1-­‐‑related	  myopathy	  	  
All  of  the  pathological  mutations  so  far  identified  in  SEPN1  are  localised  in  the  3’  (in  the  
SECIS   sequence),   in   the   selenocysteine   codon   redefinition   element   (SRE)   and   in   the  
coding   sequence.  They  consist  of  micro-­‐deletions  or   insertions   leading  to   frameshift,  
splice   site   mutations   that   cause   aberrant   pre-­‐messenger   RNA   splicing   or   single-­‐
nucleotide   changes   including   missense   mutations   that   are   centred   around   the  
selenocysteine  (Figure  13)  (Allamand  et  al.,  2006;  Castets  et  al.,  2012).  
Mutations   in   the  SEPN1   gene  were   originally   identified   as   the  genetic   cause   of   rigid  
spine  muscular  dystrophy  (RSMD1),  and  have  subsequently  been  associated  with  other  
neuromuscular  disorders:  the  classic  form  of  multi-­‐minicore  disease  (MmD),  rare  cases  
of   desmin-­‐related   myopathy   with   Mallory   body-­‐like   inclusions   (MB-­‐DRM)   and  
congenital   fiber   type   disproportion   (CFTD)   (Lescure   et   al.,   2009).   These   four   early-­‐
onset   autosomal   recessive   pathologies   show   clinical   and   morphological   overlaps,  
including  predominantly  axial  weakness,  an  early  development  of  scoliosis,  respiratory  
failure   and   a   variable   degree   of   spinal   rigidity   (Figure   14).   At   ultra-­‐structural   level,  
electron  micrographs  from  muscle  biopsy  of  affected  individuals  show  zones  of  Z-­‐lines  
streaming,  sarcomere  disorganization  and  area  of  mitochondria  depletion,  referred  to  
as   minicores   (Figure   15)   (Ferreiro   et   al.   2002).   For   these   similarities   at   clinical   and  
ultrastructural   level,   the   aforementioned   pathologies   are   now   grouped   and   called  
SEPN1-­‐RM.  




Figure  13  –  Graphical   representation  of   SEPN1  exons  and  mutations   found   in  SEPN1-­‐
RM  patients.  Exon  3,  which  is  subject  to  alternative  splicing,  is  in  light  blue.  Mutations  
in   the   selenocysteine   codon   are   in   bold,   nonsense   mutations   are   in   italics   and  
mutations  in  SRE/SECIS  regions  are  in  orange.  In  the  5’  region,  before  SEPN1  promoter,  
nuclear   factor   kappa-­‐light-­‐chain-­‐enhancer   of   activated   B   cells   (NFkB),   ER-­‐stress  
element  (ERSE)  and  CpG  islands  are  depicted  (Castets  et  al.,  2012).  
  
Figure   14   –   Representative   pictures  
of  SEPN1-­‐RM  patients:  Slender  neck  
with   lack   of   sternocleidomastoid  
bulk  and  flat  thorax  (patient  “a”,  5,5  
years   old).   Scoliosis,   lateral   trunk  
deviation   and   an   unusual  
appearance   of   lower   limbs   (patient    
“b”,  15  years  old,  and  “c”,  17  years  
old)  (Ferreiro  et  al.  2002).  















Figure  15  -­‐  Transverse  muscle  sections  with  minicores.  a,b)  left  deltoid  of  a  5  years  old  
patient  stained  with  H&E  (a)  or  myosin  adenosine  trisphosphatase,  pH  9.4  (b),  scale  bar  
=  40  µm.  Lighter  (type  I)  fibers  are  predominant  compared  to  the  dark  (type  II)  fibers.  
c,d)   right   deltoid   of   a   14   years   old   patient   stained   with   nicotinamide   adenine  
dinucleotide-­‐tetrazolium   reductase   (NADH-­‐TR)   (“c”,   scale   bar   =   25   µm)   or   succinate  
dehydrogenase  (“d”,  scale  bar  =  12,5  µm).  Both  the  stainings  show  minicores,  the  white  
areas/dots  lacking  oxidative  activity    (Ferreiro  et  al.  2002).  
  
The   spinal   stiffness   is   a   defining   feature   of   SEPN1-­‐RM   together   with   an   early  
respiratory   failure   which   represents   a   common   life-­‐threatening   condition   even   in  
ambulant  SEPN1-­‐RM  patients.  Recently  studies  point  to  weakness  and  dysfunction  of  
the   diaphragm   as   the   cause   of   the   respiratory   failure   and   suggest   nocturnal   non-­‐
invasive   ventilation   as   a   mean   of   stabilizing   the   respiratory   function   in   SEPN1-­‐RM  
patients  (Caggiano  et  al.,  2017).  In  addition,  glucose  intolerance  and  insulin  resistance  
was  reported  in  a  cohort  of  SEPN1-­‐RM  patients  suggesting  that  insulin  resistance  may  
be  an  overlooked  aspect  of  SEPN1-­‐RM  (Clarke  et  al.,  2006).  
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1.3.3	  –	  SEPN1	  characterisation	  
SEPN1  is  an  ER  membrane  protein  ubiquitously  expressed  throughout  the  body  (Petit  
et  al.,  2003).  Human  SEPN1  is  composed  by  590  amino  acids  with  a  molecular  mass  of  
68  KDa  and   its   structure  has  not  been   solved  yet.     Bioinformatics  analyses  predict  4  
sites   of   glycosylation,   a   calcium-­‐binding   domain   (EF-­‐hand)   and   3   trans-­‐membrane  
domains   in   SEPN1.   However   unpublished   results   of   protease   accessibility   assays  
suggest   that   SEPN1   is   a   type   II   membrane   protein   with   only   one   transmembrane  
domain  (Figure  16).  Most  of  the  protein  is  located  inside  the  ER  lumen,  while  a  short  
tail  at  the  N-­‐terminal  faces  the  cytosol.    On  the  ER  side  of  SEPN1,  the  selenocysteine  is  
close  to  a  cysteine  residue  and  this  dyad  of  amino  acids  resembles  the  catalytic  active  
site  of  TrxR  (Castets  et  al.,  2012).  
  
Figure   16   –   Bioinformatics   prediction   of   different   domains   in   SEPN1.   TM  
=Transmembrane   motif,   EF-­‐hand   domain   =   calcium   binding   site,   SCUG   =   Possible  
catalytic   site   containing   the   selenocysteine.   Below,   the   amino   acid   sequence   is  
presented.   The   gray   box   depicts   the      transmembrane   domain,   the  green  box   the   EF-­‐
hand  domain  and  the  red  box  the  SCUG  site.  Red  bold  letters  indicates  the  glycosylation  
sites  (Castets  et  al.,  2012).  
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SEPN1  function   is  still  not  known,  partly  because  of  the  difficulty   in  obtaining  a  pure  
protein  necessary  to  test  its  activity.  However,  biochemical  studies  have  shown  a  role  
of  SEPN1  in  redox  and  calcium  homeostasis.    
SEPN1-­‐devoid  myotubes  have  an  excess  of  oxidized  proteins  and   treatment  of   these  
cells  with  the  anti-­‐oxidant  N-­‐acetyl-­‐cysteine  decreases  the  protein  oxidation  (Arbogast  
et   al.,   2009).   In   addition,   SEPN1   co-­‐immunoprecipitates   with   Ryanodine   Receptor   1  
(RyR1),   a   calcium   release   channel   of   the   ER   whose   genetic   mutations   are   also  
associated  to  muscle  diseases  (central  core  and  minicore  diseases).  RyR1  from  SEPN1  
mutants  shows  a  reduced  ability  to  bind  its  ligand  and  modulator  ryanodine  suggesting  
that   SEPN1   interacts   with   RyR1   and   modulates   its   activity   in   a   redox-­‐dependent  
manner  (Jurynec  et  al.,  2008).  
Following  studies  have  hypothesized  that  the  CU  domain  of  SEPN1  may  be  involved  in  
an   electron   transfer   chain   with   a   proteinaceous   substrate   and   have   developed   a  
“trapping   mutant”   of   SEPN1   to   identify   proteinaceous   interactors   of   SEPN1   that  
interact   with   SEPN1   in   a   redox-­‐dependent   manner.   In   the   list   of   these   SEPN1  
interactors   sarcoplasmic   reticulum   calcium   ATPase   isoform   2   (SERCA2),   a   calcium  
pump   of   the   ER,   stands   out.   In   addition,   functional   studies   showed   that   the   rate   of  
calcium  uptake  in  the  ER  was  impaired  in  SEPN1  KO  cells  and  recovered  only  in  SEPN1  
KO  cells  expressing  a  redox  active  SEPN1  suggesting  that  SEPN1  interacts  with  SERCA2  
and  regulates  its  activity  in  a  redox-­‐dependent  manner  (Marino  et  al.,  2015).    On  the  
same  line,  the  overexpression  of  ER  oxidoreductin  1  (ERO1),  a  protein  disulfide  oxidase  
of   the  ER  whose  activity   is   associated   to   the   stoichiometric  production  of  H2O2,  was  
shown   to   be   detrimental   in   SEPN1-­‐devoid   myoblast   cell   line   suggesting   that   SEPN1  
may  counteract  ERO1  detrimental  effect  on  cells  (Marino  et  al.,  2015).  
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1.3.4	  –	  SEPN1:	  data	  from	  animal	  models	  
Given   the   lack   of   a   purified   SEPN1   that   would   have   allowed   in   vitro   mechanistic  
studies,   the  functional  studies  on  SEPN1-­‐mutant   cells  together  with  the  phenotypical  
characterisation  of  SEPN1  loss-­‐of-­‐function  animal  models  have  been  important  to  infer  
SEPN1  function.  
In   temporal   order   the   first   studies   for   the   assessment   of   SEPN1   function   were  
conducted   on   zebrafish.   Sepn1-­‐antisense   morpholino   oligonucleotide   injected   in  
zebrafish  induced  alterations  in  muscle  architecture  and  compromised  the  fish  motility  
(Figure  17)  (Deniziak  et  al.,  2007).    
  
Figure   17   -­‐   Altered   myofibrillar  
ultrastructure   in   Sepn1   morphant.  
A).   Electron   micrograph   of   WT  
muscle   showing   a   well-­‐organized  
triad.   B)   Electron   micrograph   of  
Sepn1   morphant   muscle   showing  
that   the   muscle   structure   severely  
perturbed   and   the   triad   is   not   detectable.   C)   Electron   micrograph   of   WT   muscle  
showing   that  mitochondria   (arrowheads)   are   regularly   interposed   among  myofibrills.  
D)   Electron   micrograph   of   Sepn1   morphant   showing   that   peripheral   mitochondria  
(arrowheads)  are  suspended  in  myofibril-­‐free  space.  Image  from  (Deniziak  et  al.,  2007).  
  
  
Another   zebrafish   study   started   from   the   observation   of   overlapping   muscle  
phenotypical   features   between  patients  with   RyR1  mutations   and   those  with   SEPN1  
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mutations   and   showed   that   the   same   overlapping   phenotypical   features  were   seen  
between  Ryr1   morphants   and   Sepn1   morphants   in   zebrafish.   In   addition,   this   study  
supported  a  model  in  which  SEPN1  interacts  with  RyR  and  modifies  the  redox  state  of  
RyR,  which  is  critical  for  the  regulation  of  the  calcium  flow (Jurynec  et  al.,  2008).  
The  first  SEPN1  KO  mouse  model  was  engineered  and    studied  in  2011.  This  model  is  
characterised  by  the  excision  of  exon  3  in  Sepn1,  thus  leading  to  Sepn1  transcripts  that  
are   not   stable   and   undergo   degradation.   SEPN1   KO  offspring  were   recovered   at   the  
expected   mendelian   frequency   suggesting   that   the   lack   of   SEPN1   does   not   trigger  
developmental  defects  in  mice  (Rederstorff  et  al.,  2011).  
During  adulthood,  SEPN1  KO  mice  do  not  show  any  overt  muscle  phenotype  in  normal  
cage  condition.  However,  when   these  mice  were   forced   to   increased  muscle  activity  
(regular  every  other  day  session  of  forced  swimming  for  3  months)  the  lack  of  SEPN1  
gave  rise  to  phenotypical  features  which  resemble  those  of  SEPN1-­‐RM  patients  such  as  
progressive  stiffness,  sarcopenia  of  trunk  and  limb  muscles  and  kyphosis.    
Immuno-­‐histochemical   and   morphometric   analysis   of   SEPN1   KO   mice   hind   limb  
muscles  revealed  lack  of  atrophy,  necrosis  and  fibrosis,  as  well   lack  of  changes  in  the  
ratio   oxidative   to   glycolytic   fibers,   whereas   the   back   muscles   of   SEPN1   KO   mice  
resulted  atrophic.  
Although   the   hind   limb   muscles   of   SEPN1   KO   mice   were   spared   from   any   overt  
phenotype,    regeneration  of  these  muscles  resulted  impaired  and  satellite  cells    were  
reduced  after  injections  of  cardiotoxin  (a  myonecrotic  agent)(Figure  18)  suggesting  the  
importance  of  SEPN1  in  muscle  regeneration  (Castets  et  al.,  2011).  
A  different  SEPN1  KO  mouse  was  generated  in  Beggs’  laboratory  that,  as  the  previous  
mouse  model,  doesn’t  express  SEPN1  in  any  tissues.  In  this  model  exon  9  in  the  Sepn1  
gene   was   replaced   by   a   Neomycin   cassette,   causing   a   frameshift   that   lead   to   a  
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truncated   SEPN1   protein.   Since   exon   9   encodes   for   the   selenocysteine   residue,   the  
abnormal  SEPN1  protein   is  non-­‐functional.  As   for  the  previously  described  SEPN1  KO  
model,  also  in  this  case  the  levels  of  Sepn1  transcripts  were  greatly  reduced  compared  
to  the  WT  mice.    Interestingly,    an  abnormal  lung  development  together  with  enlarged  
alveoli  and  decreased  tissue  elastance  was  seen  in  this  SEPN1  KO  mice,  suggesting  the  
possibility   that   SEPN1   loss   may   affect   not   only   muscle   but   also   lung   function  
(Moghadaszadeh  et  al.,  2013).  It   is  not  known  if  abnormal  lungs  were  also  developed  
by   SEPN1   KO   mice   in   the   previously   described   mice   model,   since   the   non-­‐muscle  
tissues  that  were  analysed  did  not  include  lungs.  
The   Beggs’   SEPN1   KO  mouse   does   not   show   an   overt   muscle   phenotype.   However  
histochemical  analyses  on  SEPN1  KO  muscles  suggest  that  the  combined  deficiency  of  
the   anti-­‐oxidant   vitamin   E   and   daily   running   sessions   lead   to   minicores,   which   are  
areas  of  mitochondria  depletion,  and  a  defining  feature  of  SEPN1-­‐RM  muscle  biopsies  
(Moghadaszadeh  et  al.,  2013).  
Minicores   on   sections   of   gastrocnemii   of   SEPN1   KO  mice   were   also   observed   after  
muscle   injection  of  an  adenovirus  driving  ERO1  expression,  suggesting  that  an  excess  
of   the   ER   stress   responsive   protein   disulphide   oxidase   ERO1   is   detrimental   for   the  








Figure  18  –  Representative  H&E  stainings  of   tibialis  anterior   from  mice   injected  with  
single   (SI)   or   double   (DI)   injections   of   cardiotoxin,   after   7,   15   or   30   days   from   the  
injection.  The  lack  of  SEPN1  impaired  the  regeneration  of  muscle  fibers  mainly  after  a  
second   injection   of   cardiotoxin.   Black   arrows   indicate   adipocytes,   black   arrowhead  
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1.4	   –	   Endoplasmic	   reticulum	   stress	   and	  
unfolded	  protein	  response	  
	  
	  
The   endoplasmic   reticulum   (ER)   is   the   largest   organelle   in   the   cell   and   is   the  
compartment   in   which   the   proteins   destined   for   the   secretory   pathway   and   cell  
surface  are  folded.  The  proteins  enter  in  an  unfolded  state,  and  only  leave  when  they  
are   correctly   folded   and   assembled.   It   is   predicted   that   about   20%   of   the   proteins  
encoded  by  the  human  genome  enter  the  secretory  pathway.  The  process  of  folding  in  
the  ER  requires  enzymes  to  catalyse  the  steps  that  are  critical  to  reach  the  functional  
protein   conformation,  and  chaperones   to  prevent  misfolding  and   the  aggregation  of  
folding   intermediates.   Highly   secretory   cells   and   tissues   of   multi-­‐cellular   organisms,  
such  as  those  involved  in  the  immune  and  endocrine  systems,  have  become  specialized  
for  secretion  and  are  therefore  particularly  reliant  on  ER  integrity  and  protein  folding.  
ER  protein  misfolding  occurs  when  the  load  of  proteins  in  the  ER  exceeds  the  capacity  
of   the   folding  machinery  and   results   in  ER   stress.  ER   stress   is   sensed  by   three   stress  
receptors   in   mammals:   inositol-­‐requiring   enzyme   1   (IRE1),   protein   kinase   R-­‐like   ER  
kinase  (PERK),  and  activating  transcription  factor  6  (ATF6)  (Ron  and  Walter,  2007).    
These   sensors   are   ER   transmembrane   proteins  with   a   stress-­‐sensing   luminal   portion  
and  a    cytoplasmic  effector  domain.  When  these  three  stress  receptors  sense  ER  stress,  
generally  following  the  dissociation  of  the  chaperone  binding  immunoglobulin  protein  
(BIP)   from   the   three   receptors,   they   activate   a   homeostatic   response,   the   Unfolded  
Protein  Response  (UPR),  that  swings  into  action  by  attenuating  protein  translation  and  
promoting   the   transcription   of   chaperones   to   rectify   the   accumulation   of  misfolded  
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proteins  in  ER,  thus  generally  relieving  ER  stress.  Phylogenetically,  the  most  conserved  
of  the  three  receptors  is  IRE1,  that  is  a  kinase  and  endoribonuclease  that  promotes  the  
unconventional   splicing   of   an   intronic   region   of   X   box   binding   protein   1   (XBP1)   that  
subsequently  becomes  a  transcription  factor  of  the  genes   involved   in  protein  folding  
and  ERAD  (Figure  19).    
  
Figure  19  -­‐  IRE1  pathway.  Following  ER  
stress   IRE1   dimerizes   and   exerts   its  
endoribonucleolytic   activity   on   XBP1  
mRNA.   Spliced   XBP1   mRNA   (XBP1s)  
encodes   for   a   transcriptional   factor  
that   translocates   to   the   nucleus.   The  
unspliced   XBP1   mRNA   encodes   an  




Following  ER  stress,  PERK  dimerizes  in  the  ER  membrane  and  auto-­‐phosphorylates  its  
cytosolic  protein  kinase  domain.  The  activated  PERK  attenuates  protein   synthesis  by  
phosphorylating  eukaryotic  initiation  factor  2-­‐alpha  (eIF2-­‐α)  (Figure  20).  The  ER  stress-­‐
activated   ATF6   traffics   to   the   Golgi,   where   it   is   proteolytically   cleaved   from   its  
transmembrane   domain,   and   subsequently   reaches   the   nucleus   where   it   acts   as   a  
transcription  factor  for  chaperones  such  as  BIP/GRP78  and  GRP94  (Figure  21).  The  ER  
stress   response   therefore   acts   by   inhibiting   protein   translation   through   the   PERK  
pathway  and  favouring  protein  degradation  and  the  induction  of  chaperones  through  
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the   IRE1  and  ATF6  branches.  This  coordinated  action  of  protein  degradation  and  the  
induction  of  chaperones  relieves  ER  stress  and  re-­‐establishes  homeostasis  and  suggest  
an   important   role   of   the   UPR   as   a   survival   pathway   for   ER   stressed   cell   (Ron   and  
Walter,  2007).  
However,  a  form  of  unrelieved  chronic  ER  stress  may  occur  and  lead  to  cell  death.  All  
three   arms   of   the   UPR   contribute   to   the   transcriptional   activation   of   the   apoptotic  
gene   C/EBP   homologous   protein   (CHOP).   CHOP   deletion   protects   severely   stressed  
cells  against  death,  which  suggests  that  CHOP  has  evolved  (in  vertebrates)  to  associate  










Figure   20   -­‐   PERK   pathway.   ER   stress   is   sensed   by   PERK   on   the   ER  membrane.   PERK  
dimerizes   and   becomes   active   by   auto-­‐phosphorylation   of   its   cytosolic   domain.  
Activated  PERK  inhibits  elf2  by  phosphorylating  its  α  subunit.  The  decrease  of  activated  
elf2  lowers  the  amount  of  newly  synthesized  proteins  (Ron  and  Walter  2007).     
                        












Figure  21  -­‐  ATF6  pathway.  BiP  proteins  detach  from  ATF6  during  ER  stress  causing  ATF6  
to  translocate  to  Golgi.  Here,  ATF6  is  cleaved  by  the  lumenal  site  1  protein  (SBP1)  and  
the  intra-­‐membrane  site  2  proteases  (SBP2).  The  cleaved  portion  of  ATF6  moves  from  
the   cytoplasm   to   the   nucleus  where   it   acts   as   a   transcription   factors   of   UPR   target  
genes  (Ron  and  Walter,  2007).  
  
However,  the  relationships  between  CHOP  and  the  apoptosis  machinery  are  unlikely  to  
be   the   only   reason   that   explains  why   CHOP-­‐devoid   cells   are   protected   from   death.  
Indeed,  comparisons  of  wild-­‐type  and  CHOP-­‐/-­‐  cells  indicate  that  the  latter  experiences  
less  ER  stress  when  confronted  with  the  same  perturbation  of  protein  folding  in  their  
ER  and  therefore  suggest  a  connection  between  CHOP  and  ER  stress.  
The  same  study  revealed  growth  arrest  and  DNA  damage-­‐inducible  protein  (GADD34)  
and  ERO1    as  transcriptional  targets  of  CHOP  and  showed  that  they  might  be  involved  
in   the   failure   of   the   homeostasis.   GADD34   recruits   protein   phosphatase   1   (PP1)   to  
dephosphorylate  eif2-­‐alpha  and   thus  promotes   reactivation  of   the  protein   synthesis,  
that  may  be  detrimental   for  example   in   case  of   genomic  mutations   that  give   rise   to  
misfolded  proteins    (Marciniak  et  al.,  2004).  
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ERO1,  the  main  protein  disulfide  oxidase  of  the  ER,   is  also  a  transcriptional   target  of  
CHOP   and   a   failure   to   activate   ERO1   further   explains   the   less   oxidizing   conditions  
observed   in   the   ER   of   stressed   CHOP-­‐/-­‐   cells   and  may   contribute   to   their   ability   to  
survive  to  high  levels  of  ER  stress  (Marciniak  et  al.,  2004).  
The   enzymatic   activity   of   ERO1   as   protein   disulphide   oxidase   is   associated   with   a  
stoichiometric   production   of   H2O2:   one   molecule   of   H2O2   is   generated   for   each  
disulfide   bond   introduced   on   new   client   proteins,   thus   burdening   cells   with   a  
potentially   toxic   oxidant   that  must   be   disposed   of   safely   (Pollard   et   al.,   1998).      This  
connection  highlights  the  dual  nature  of  ERO1:  from  one  side  is  an  important  enzyme  
that   is   involved   in   protein   folding   from   the   other   side   generates   H2O2   that   at   high  
concentrations  is  toxic  for  cells.  
  
  




  Figure   22   –   Cartoon   depicting   the   reaction   of   disulphide   bond   formation   of   client  
proteins  involving  the  enzymatic  activity  of  ERO1  and  PDI.  The  electrons  move  from  the  
oxidized,   disulphide   bonded   protein   to   PDI   and   then   ERO1.   The   final   acceptor   of  
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1.5.1	  –	  Skeletal	  muscle	  
Skeletal  muscle  accounts  for  40%  of  total  body  weight  and  contains  more  than  half  of  
all  body  proteins  (Frontera  and  Ochala,  2015).  
Skeletal  muscle  is  composed  by  myofibers  (muscle  fibers  characterised  by  the  fusion  of  
several   muscle   cells)   surrounded   by   connective   tissue   which   characterise   the  
extracellular  matrix  (ECM).  The  size  of  each  muscle  is  determined  by  the  number  and  
the  size  of  the  myofibers.  
Epimysium   is   the   outer   connective   tissue   surrounding   the   whole   skeletal   muscle.  
Inside,   groups   of  myofibers   are   kept   together   by   another   layer   of   connective   tissue  
named   perimysium.   Lastly,   the   single   muscle   fiber   is   surrounded   by   its   own  
plasmamembrane,  the  sarcolemma,  and  by  the  endomysium.  
Each  myofiber   is  composed  by  thousands  of  myofibrils   inside  the  cytoplasm  that  are  
composed   by   myofilaments   of   actin   (thin   filaments)   and   myosin   (thick   filaments),  
which   form   units   called   sarcomeres.   Sarcomeres,   the   basic   contractile   units   of   the  
skeletal  muscle,  are  parallel  subunits  repeated  along  the  myofibril  and  are  aligned  with  
the   sarcomeres   in   the   next   myofibril,   depicting   a   pattern   that   causes   the   fibers   to  
appear  striped,  hence  the  term  “striated”  for  the  skeletal  muscle  (Figure  23).    
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Figure   23   –   General   skeletal   muscle   architecture.   From   epimysium   to   endomysium,  
different  layers  of  connective  tissue  wrap  thousands  of  myofibers  (Kraemer,  W.J.,  Fleck,  
S.J.  &  Deschenes,  M.R.,  2012).  
	  
1.5.2	  –	  Skeletal	  muscle	  and	  its	  ER	  	  
An  important  component  of  the  sarcomere  is  the  “sarcoplasmic  reticulum”,  SR.  Indeed,  
inside   muscle   fibers   there   is   not   only   ER   but   also   an   extensive   myofibril-­‐associated  
network  of  membranes  termed  SR,  which  is  a  differentiated  domain  of  the  muscle  ER  
dedicated  to  calcium  handling.  SR  originates  from  ER  during  the  early  stage  of  muscle  
differentiation  when  the  ER  enlarged  in  volume  and  myofibrils  surrounding  it  like  a  net.  
The  SR  is  specialized  to  serve  muscle  contraction  through  two  distinct  actions:  one  is  
the   uptake   and   storage   of   calcium   ions   which   is   mediated   by   the   calcium   ATPase  
SERCA,  distributed  over  the  extensive  free  SR.  The  second  function  is  the  rapid  release  
of  calcium  that  occurs  at  the  level  of  the  junctional  SR  (JSR)  that  is  in  close  contact  with  
the   transverse   tubule   (T   tubule),   invaginations   of   the   plasmamembrane   carrying   an  
electrical  signal.  The  JSR-­‐T  tubule  association  forms  the  triad  or  Calcium  release  Unit  
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(CRU)  and  contain   the  complex   for   the  excitation-­‐contraction  coupling   (EC-­‐coupling).  
The   EC-­‐coupling   links   the   action   potential,   carried   along   a   T-­‐tubule,   to   SR   calcium  
release   via   the   Ryanodine   Receptors   (RyRs).   In   conclusion  muscle   fibers   contain   ER,  
that  is  dedicated  to  protein  synthesis,  folding  and  transport,  the  free  SR,  whose  surface  
has  a  high  density  of  SERCA,  and  therefore  allows  calcium  refill   in  the  SR  lumen  after  
muscle  contraction,  and   in  direct   continuity  with  the   free  SR  there   is   the  JSR,  that   is  
involved   in   calcium   efflux   following   an   action   potential   (Volpe   et   al.   1992;   Kaisto  
2003)(Porter  1945;  Franzini-­‐Armstrong  2018).  
To  meet  metabolic  demand  during   contraction  and   relaxation,   skeletal  muscle   fibers  
require   a   large   amount   of   adenosine   triphosphate   (ATP),   mostly   supplied   by  
mitochondria  that  populate  the  slow-­‐twitch  (type  I)  fiber  and  fast  twitch  (type  II)  fibers  
with  some  differences  in  abundance  and  distribution.    Type  I  fibers  are  highly  oxidative  
and   have   the   highest   mitochondrial   content   including   triadic   and   longitudinal  
mitochondria  whereas   type   II   fibers  have   not   only   less  but  almost  exclusively   triadic  
mitochondria   (Figure   24).   In   the   mitochondrial   cristae,   the   respiratory   complexes  
involved   in   the   oxidative   phosphorylation   (OxPhos)   system   are   located.   The   OxPhos  
converts   the   energy   derived   from   nutrients   in   ATP.   The   efficiency   of   this   oxidative  
metabolism   critically   depends   on   the   Krebs   cycle   (that   metabolizes   sugars)   and   β-­‐
oxidation   (that   metabolizes   fatty   acids),   respectively   for   the   generation   of   reduced  
nicotinamide   adenine   dinucleotide   (NADH)   and   reduced   flavin   adenine   dinucleotide  
(FADH2),   which   feed   electrons   to   the   electron   transport   chain.   Electrons   flow   is  
coupled  with   the   translocation  of  protons  across   the   inner  mitochondrial  membrane  
(IMM),   generating   a   transmembrane   electrochemical   gradient,   which   is   finally  
exploited   by   ATP   synthase   to   generate   ATP.   Oxidative   metabolism   is   controlled   by  
calcium   ions   which   activate   several   key   metabolic   enzymes,   including   pyruvate  
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dehydrogenase,  alpha-­‐ketoglutarate,  isocitrate  dehydrogenase,  as  well  as  complexes  I,  
III,   IV   and   V   of   the   electron   transport   chain.   Therefore,  mitochondrial   calcium   is   an  
important  regulator  of  ATP  production.  In  murine  skeletal  muscles,  both  ER  and  SR  are  
closely   associated   to   mitochondria   and   about   a   quarter   of   the   outer   surface   of  
mitochondria  is  very  close  to  the  JSR.  Studies  of  electron  microscopy  indicate  that  the  
outer  mitochondrial  membrane   (OMM)   is  on  an  average  of  130  nm   from   the   site  of  
RyR-­‐mediated   calcium   release.   These   measurements   support   the   concept   of   short-­‐
term   formation   of   high   calcium  microdomains   that   allow   efficient   calcium  exchange  
between   ER/SR   and   mitochondria   and   suggests   that   ER/SR   calcium   levels   may  
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Figure   24   -­‐   Cartoon   of   the   spatial   organization   of   ER   and   SR   domains.   An   action  
potential  is  transmitted  from  the  motoneuron  to  the  neuromuscular  junction  (NJ),  and  
from  NJ  to  the  T-­‐tubules   (TT).     The  TT  depolarization   is  sensed  by  the  dihydropyridine  
receptor   (DHPR),  which   is   in   close   physical   contact  with   RyR1   on   the   jSR   that   is   also  
connected   to   triadic  mitochondria   (tM).   As   a   consequence,   RyR1   opens   and   calcium  
leaves  the  SR.  SERCA  pumps  are  mostly  distributed  on  the  free  SR  (fSR)  and  promote  
calcium  re-­‐uptake  in  fSR,  that  is  in  contact  with  longitudinal  mitochondria  (lM).  More  
distal  to  the  TT,  close  to  nuclei  (N)  and  Golgi  (G)  there  is  a  canonical  ER  that  fulfils  the  
function  of  protein  synthesis  and  folding  and  is  prone  to  ER  stress.  
	  
1.5.3	  –	  ER	  stress	  in	  skeletal	  muscle	  	  
The  relevance  of  ER  stress  and  the  consequent  UPR  in  skeletal  muscle  are  suggested  by  
the   fact   that   these   are   among   the   primary   processes   triggered   by   altered  
environmental   cues   such   as   long-­‐distance   running   or   a   simple   dietary   alteration   in  
skeletal  muscle  (Wu  et  al.,  2011)  (Deldicque  et  al.,  2010).  
Skeletal  muscle  is  interesting  with  respect  to  the  UPR  because  it  has  a  limited  role  in  
protein  secretion.  However,  muscle  contraction  and  relaxation  are  finely  regulated  by  
changes   in   the   intracellular   calcium   (Ca2+)   concentration   that   also   influences   protein  
folding  into  the  ER.    
Changes  in  redox  status  of  both  cytoplasmic  and  luminal  cysteines  affect  the  activity  of  
calcium   channels   and   pumps   that   play   a   crucial   role   in   the   excitation   contraction  
coupling  but  are  also  important  regulators  of  ER/SR  calcium  levels.  For  example,  mixed  
disulfides   between   the   ER-­‐localised   oxidoreductase   endoplasmic   reticulum   resident  
protein   44   (ERp44)   and   cysteines   on   the   third   luminal   loop   of   Inositol   1,4,5-­‐
trisphosphate   receptor   isoform   1   (IP3R1)   inhibit   the   activity   of   this   ligand-­‐regulated  
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calcium   release   channel   (Higo   et   al.,   2005),   and   cysteine-­‐dependent   interactions  
between   the   oxidoreductase   ERp57   and   the   fourth   luminal   loop   of   SERCA   2b   inhibit  
calcium   reuptake   into   the   ER   by   this   ATP-­‐driven   pump   (Li   and   Camacho,   2004).  
Similarly,   RyR1   activity   is   also   regulated   in   a   redox-­‐dependent  manner;   for   example,  
H2O2-­‐mediated  oxidation  generated  by  SR-­‐localised  NADPH  oxidase  isoform  4  (NOX4)  
affects  the  redox  state  of  regulatory  RyR1  thiols,  leading  to  a  leaky  RyR1  and  affecting  
muscle  performance  (Sun  et  al.,  2011).  
This   suggests   that   altered   redox   poise   in   skeletal   muscle   may   affect   the   activity   of  
calcium  channels  and  pumps  and  therefore  from  one  side  enfeebles  the  mechanism  of  
excitation-­‐contraction  coupling  and  from  the  other  side   impairs  the  calcium  levels  of  
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1.6.1	  –	  Ascorbic	  acid:	  an	  introduction	  	  
Ascorbic   acid   (ASC)   is   an   organic   compound   with   two   enantiomeric   isoforms:   L-­‐
ascorbate   is   the  most   common  while  D-­‐ascorbate  can  be  produced   synthetically  but  
has  no  biological  function.    
The   biosynthetic   pathway   of   ASC   in   animals   starts   from   glucose,  which   is   converted  
into  ASC  as  a  result  of  a  four-­‐step  enzyme-­‐mediated  reaction.  The  organ  in  which  this  
biosynthetic  reaction  takes  place  has  changed  in  different  species  during  evolution:  it  
is  the  kidney  in  amphibians  but  the  liver  in  mammals,  possibly  because  a  larger  organ  
is   a   more   appropriate   mean   of   producing   such   a   fundamental   substance   in   more  
complex  organisms.  However,  the  biosynthesis  of  ASC  has  disappeared  in  guinea  pigs,  
monkeys  and  humans  since  the  gene  of  L-­‐gulono-­‐lactone  oxidase  (the  last  enzyme  in  
the  biosynthetic  pathway  of  ASC)   (GULO)  has  acquired  mutations   that  have   led   to   it  
becoming   a   pseudogene,   thus   leaving   these   species   incapable   of   synthesising   their  
own  ASC.  As  a   consequence  humans  are  auxotroph   for  ASC  and   for   them  ASC   is   the  
vitamin  C  (Chatterjee,  1973;  Drouin  et  al.,  2011)(Figure  25  and  Figure  26).  




Figure  25  -­‐  Differences   in  the  biosynthetic  pathway  of  ASC  between  plant  and  animal  
kingdoms.   Plants   are   prototroph   for   ASC,   human   and   other   primates   do   not   have   a  




Figure  26  -­‐  Schematic  graphical  representation  of  exon-­‐intron  structures  of  animal  Gulo  
genes.   The   conserved   11   exons   of   Gulo   among   vertebrates   are   depicted   by   capital  
letter.  Black  boxes  depict  homologous  exons,  exons  that  have  accumulated  too  many  
mutations   or   completely   missing   are   depicted   in   red   marked   as   “L”   (lost).   ASC+  
indicates  species  that  are  prototroph  for  ASC  and  ASC-­‐  species  that  are  auxotroph  for  
ASC.  
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Nutritional   deficiency   of   ASC   causes   scurvy   and   it   occurs   when   ASC   plasma  
concentrations  are   less  than  0.2  mg/dL.  Scurvy   is  characterised  by  symptoms  such  as  
follicular  hyperkeratosis,  bleeding  gums,  pethechiae  and  impaired  wound  healing  due  
to   connective   tissue   defects,   although   less   serious   symptoms   such   as   gingival  
inflammation  and  fatigue  are  the  earliest  markers  in  vitamin  C-­‐deficient  humans  who  
are  still  not  completely  scorbutic  (Levine  et  al.,  1996).    
Chronic  low  levels  of  ASC  in  the  diet  bring  to  arthalgia  (joint  pain)  in  knees,  ankles  and  
wrists,  with  the  possibility  of  bleeding  in  the  joint  areas.  Muscle  pain  is  also  a  common  
feature  (Fain,  2005).   In  a  guinea  pigs  study   it  was  postulated  that  a  diet  poor   in  ASC  
impairs  skeletal  muscles  ability  to  recover  after  injuries  (Boyle  and  Irving,  1951).    
  
1.6.2	  	  –	  ASC	  metabolism	  and	  uptake	  
After   ingestion,   the   body   receives   both   ASC   and   ascorbate,   which   inter-­‐converts  
depending   on   pH   status.   As   an   anti-­‐oxidant,   ASC   can   undergo   an   oxidative   reaction  
that  leads  to  the  loss  of  two  electrons  and  the  formation  of  oxidised  dehydroascorbic  
acid   (DHA).   This  may   occur   as   a   result   of   food   processing   techniques   or   within   the  
gastrointestinal  tract,  after  which  it  can  be  reduced  back  to  ASC  by  means  of  various  
mechanisms   (Calcutt,   1951;   Wells   and   Xu,   1994;   Wilson,   2002).   The   results   of  
pharmacokinetic   experiments   suggest   that,   after   oral   ingestion,   plasma   vitamin   C  
concentrations   are   strictly   controlled   by   intestinal   absorption,   tissue   transport   and  
renal   reabsorption,   whereas   higher   plasma   concentrations   can   only   be   reached   by  
means  of  intravenous  administration,  which  by-­‐passes  intestinal  absorption  (Levine  et  
al.,  2011).  
ASC  is  transported  inside  cells  by  the  sodium-­‐dependent  vitamin  C  transporters  SVCT1,  
SVCT2   and   SVCT3,   which   are   localised   on   the   cell   membrane.   Given   its   chemical  
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similarity   to   glucose,  DHA   is   taken   up   by   some  members   of   the   glucose   transporter  
(GLUT)  family  (Rumsey  et  al.,  2000).    
The   findings   of   early   studies   of   isolated   microsomes   by   Banhegyi   and   Benedetti  
suggested  that  ASC  and  DHA  are  both  taken  up  by  the  ER,  but  DHA  uptake  is  preferred  
(Bánhegyi  et  al.,  1998).  The  same  authors  and  others  later  showed  that  the  transport  
of  DHA  into  the  ER  is  mediated  by  ER  membrane-­‐localised  GLUT10,  the  gene  which  is  
mutated   in   patients   with   arterial   tortuosity   syndrome   (Callewaert   et   al.,   2008;  
Gamberucci  et  al.,  2017;  Segade,  2010).  It  has  also  been  shown  that  SVCT2  is  localised  
on   the   ER   membrane   and   can   mediate   the   uptake   of   ASC   (Figure   27.)   (Muñoz-­‐
Montesino  et  al.,  2014).    
Figure  27  -­‐  Graphical  representation  
of   ASC   and   DHA   transporters.   DHA  
is  actively  transported  inside  the  cell  
by  GLUT  transporters  and  inside  the  
ER   by   GLUT10.   ASC   enters   the   cell  
through   SVCT1,   SVCT2   channels:  
once   in   the   cytoplasm   it’s  
transported  in  the  ER  by  SVCT2. 
	  
1.6.3	  –	  Antioxidant	  properties	  of	  ASC	  
The  need  to  ensure  that  the  ER  has  an  efficient  anti-­‐oxidant  system  is  highlighted  by  
the  fact  that   it  contains  enzymes  that  generate  H2O2:  ERO1   is   induced  during  the  ER  
stress  response  and  its  activity  is  associated  with  a  stoichiometric  production  of  H2O2  
(Zito,   2015).   In   addition,   there   are   other   sources   of  H2O2   inside   the   ER   (such   as   the  
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membrane-­‐localised   NOX4)   or   the   close   vicinity   to   mitochondria   which,   given   their  
phosphorylative  oxidation,  are  one  of  the  main  sources  of  cellular  H2O2  production.    
Like   ERO1   and   peroxiredoxin-­‐4   (PRDX4)   (in   enzymatic   way),   DHA   (in   non-­‐enzymatic  
way)   is   involved   in   the   re-­‐oxidation   of   protein   disulfide   isomerase   (PDI)   during  
oxidative   protein   folding,   which   suggests   that   the   protein   folding   is   in   some   way  
related  to  ASC  metabolism.  However,   in  vitro  assays   indicate  that  this  reaction   is   too  
slow   to   be   the   main   pathway   for   the   intra-­‐cellular   reduction   of   DHA   to   ASC.   In  
addition,  it  has  been  shown  that  ASC  can  reduce  the  sulphenic  groups  generated  by  an  
H2O2  attack  on  a  protein   thiol   through  a  2-­‐electron  oxidation   (Tavender  et  al.,   2010;  
Zito,  2013).  After  the  2-­‐electron  oxidation  of  ASC  to  DHA,  DHA  may  follow  one  of  two  
routes:  hydrolysis  to  2-­‐3  diketo-­‐l-­‐gulonate  (which  cannot  be  converted  back  to  ASC  and  
therefore  represents  a  net  loss  of  cellular  ASC)  (Figure  28)  or  enzymatic  re-­‐conversion  
to  its  reduced  form  through  the  glutathione-­‐ascorbate  cycle  (however,  although  this  is  
present  in  plants,  it  is  not  known  whether  it  exists  in  the  ER  of  animal  cells)  (Bode  et  
al.,   1990;   Noctor   and   Foyer,   1998).   Once   again   in   relation   to   its   properties   as   a  
reductant,  ASC  is  necessary  to  keep  ferrous  iron  in  a  reduced  state  at  the  active  site  of  
ER   luminal   Fe(II)/2OG-­‐dependent   dioxygenases   (e.g.,   prolyl   hydroxylases   and   lisyl  
hydroxylases),   that   are   enzymes   involved   in   the   hydroxylation   of   collagen,   an  
important  modification  for  the  formation  of  the  compact  triple  helix  of  collagen.  This  
modification   is   crucial   since   it   makes      collagen   competent   for   the   secretion   and  
therefore  it  can  be  deposited  in  the  ECM  (Myllyharju,  2008)(Figure  29).    
ASC,  by  means  of  its  oxidized  form  DHA,  and  ER  stress  appear  to  be  somehow  linked.  
In  fact,  ASC  can  decrease  oxidative  stress  and  accumulation  of  unfolded  proteins  inside  
the  ER  lumen,  by  re-­‐oxidizing  PDI  and  countering  the  effects  of  H2O2  accumulation.    




Figure  28  -­‐  Different  states  of  ASC.  The  natural  occurring  form  of  ASC  is  the  L-­‐ascorbic  
acid,  which  exerts  the  anti-­‐scorbutic  function.  This  form  is  present  at  acidic  pH.    If  the  
pH   is  more  basic   (pH  ~  7)  ASC   is  present  as  a  mono-­‐anion,  L-­‐ascorbate.  In  an  oxidant  
environment,   L-­‐ascorbate   is   oxidised   to   dehydroascorbic   acid   (DHA),   which   can   be  
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Figure  29  -­‐  Redox  reactions   involving  ASC.  DHA  and  ERO1  are  respectively   involved  in  
the  non-­‐enzymatic  and  enzymatic  reaction  of  PDI-­‐re-­‐oxidation  during  oxidative  protein  
folding  (1  and  2).  ASC  may  reduce  protein  sulphenylation  due  to  an  H2O2  attack  on  a  
protein  thiol.  Following  the  oxidation  of  ASC  to  DHA,  DHA  is  subject  to  hydrolysis  at  2-­‐3  
diketo-­‐l-­‐gulonate,  which  cannot  be  converted  back  to  ASC  and  therefore  represents  a  
net  loss  of  intra-­‐cellular  ASC  (3).  Inside  the  ER,  ASC  is  required  to  maintain  the  reduction  
of  ferrous  iron  at  the  active  site  of  ER  luminal  Fe(II)/2OG-­‐dependent  dioxygenases  (e.g.,  
prolyl   and   lisyl   hydroxylases,   P4H   and   LH),   which   are   enzymes   involved   in   the  
hydroxylation  of  collagen  (4).  
  
  
ASC  is  transported  and  present  in  almost  all  tissues.  Regarding  skeletal  muscle,  ASC  is  
transported  by  the  high-­‐affinity,   low  capacity  transporter  SVCT2  (Low  et  al.,  2009).   It  
has  been  estimated  that  skeletal  muscle  contains  relatively  little  ASC  in  comparison  to  
other  tissues  (approximately  3-­‐4mg/100g  of  muscle)  (Savini  et  al.,  2005),  but  the  large  
amount  of  skeletal  muscle  means  that  it  stores  almost  70%  of  the  total  AA  in  the  body  
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The   loss   of   function   of   SEPN1   in   humans   gives   rise   to  myopathy,   but   the   lack   of   an  
obvious  muscle   phenotype   in   SEPN1   knock-­‐out   mice   (SEPN1   KO)   (Rederstorff   et   al.,  
2011)  and  the  sensitivity  of  this  model  to  oxidative  stress  lead  us  to  postulate  that  the  
redox  function  of  SEPN1   is  compensated   in  the  endoplasmic  reticulum  of  the  murine  
muscle.   The   consequences   of   the   absence   of   SEPN1   on   the  muscle   function  will   be  
evaluated  with  different  approaches.  The  role  of  ascorbic  acid  in  covering  the  function  
of   SEPN1,   the   impact   of   the   loss   of   SEPN1   in   diaphragm   and   the   effect   of   external  
factors  able  to  trigger  ER  stress  such  as  a  high-­‐fat  diet.  
  
SPECIFIC  AIMS:  
•   To   investigate   if   ASC   can  mimic   SEPN1   function   in   the   ER.   This   arrangement  
would  explain  why  mice,  which  are  still  able  to  synthesize  ASC,  are  protected  
against  the  absence  of  SEPN1.  To  test  the  hypothesis  that  ASC  is  a  redundant  
factor  of  SEPN1,  a  mouse  model  dependent  on  exogenous  ASC  for  survival  will  
be   generated   and   crossed   with   SEPN1   knock-­‐out   mice   in   order   to   obtain  
compound  mice  that  are  devoid  of  SEPN1  and  dependent  on  exogenous  ASC.  
These   compound  mutants   will   be   used   to   evaluate   the   effect   of   the   lack   of  
SEPN1   on   the   stress   of   the   endoplasmic   reticulum   (ER   stress)   and   muscle  
phenotype.    
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•   Different  muscles  (hind  limb  muscles  and  diaphragm)  of  SEPN1  KO  mice  will  be  
analysed  for  the  presence  of  pathological  signs  and  ER  stress.  
•   Environmental  cues  as  high  fat  diet,  that  is  known  to  trigger  ER  stress  in  muscle,  
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3.1.1	  –	  Preliminary	  data	  
It  was  already  observed  that  the  ER-­‐resident  ASC  may  be  involved  in  an  electron  redox  
reaction  that,  by  relieving  ER  proteins  of  their  hyperoxidised  state,  converts  ascorbate  
into  an  unstable  oxidised  dehydroascorbate  derivative  with  a   consequent  net   loss  of  
ASC   (Zito   et   al.,   2012).   In   order   to   test   the   ASC   metabolism   in   SEPN1   deficient  
myoblast,  we  stably  lowered  SEPN1  levels  by  means  of  lentiviral  shRNA  in  C2C12  cells,  
a  myoblast  cell   line.     The  resulting  SEPN1  Knock  down  (KD)  cells  had  70%  less  SEPN1  
and  we  compared  these  cells  with  mock  infected  cells  (WT).  To  explore  the  turnover  of  
ASC  in  WT  and  SEPN1  KD  C2C12  cells  we  used  a  quantitative  high-­‐performance  liquid  
chromatography  (HPLC)-­‐based  method  that  selectively  measures  the  reduced  form  of  
ASC  (Fig.30).  
              Figure   30   -­‐   HPLC   traces   of   ASC.      The   upper  
traces   show   a   peak   signal   for   the   standard  
ASC  that  is  not  detected  for  the  standard  DHA  
indicating   that   the  method   is   specific   for   the  
detection   of   ASC   and   does   not   detect   its  
oxidized   form,  DHA.  The   lower   traces   show  a  
peak  signal  of  ASC   in  C2C12  cells   loaded  with  
DHA,   indicating   a   conversion   of   the   latter   to                                  
reduced  form  of  ASC  inside  the  cells.  
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After  a  short  pulse  of  DHA  (DHA  was  used  as  is  more  efficiently  taken  up  than  ASC)  in  
WT   and   SEPN1   KD   C2C12   cells,   the   levels   of   ASC  were  measured   in   both   cells.   The  
decay  of  ASC  was  observed  to  be  faster  in  the  SEPN1  KD  cells  than  in  the  WT  cells  (Fig.  
31)  suggesting  a  more  rapid  turnover  of  ASC  in  SEPN1  KD  cells.  
Figure   31   –   Accelerated   ASC  
turnover   in  SEPN1  KD  cells.  WT  
and   SEPN1   KD   cells   were  
challenged   with   DHA   and   later  
the   intracellular   metabolism   of  
the   ASC   examined   by   HPLC.  
Briefly,  cells  were  supplemented  
with  25  µM  of  DHA  for  30  minutes  and  then  the  ASC  cellular  content  was  measured  at  
different  time  points  after  withdrawal  of  the  oxidized  vitamin  from  the  cellular  media.  
The  height  of  the  peaks  at  any  time  point  is  plotted  after  the  arbitrary  value  of  1  that  
had  been  assigned  to  the  highest  peak.  
3.1.2	  –Mouse	  model	  
Unlike   human   and   zebrafish,   in   which   SEPN1   loss   of   function   gives   rise   to   an   overt  
muscle   phenotype,   SEPN1   KO   mouse   does   not   show   any   apparent   phenotypical  
alteration  and  thus  seems  to  be  protected  by  the  possible  existence  of  compensatory  
pathways.  
The  faster  turnover  of  ASC  in  SEPN1  KD  cells  may  suggest  that  this  vitamin  moderates  
hyperoxidation   and   thus   may   preserve   muscle   function   in   SEPN1   KO   mouse.  
Accordingly,  mice  are  still  capable  of  producing  ASC  and  thus  can  better  cope  with  the  
lack  of  SEPN1,  whereas  human  and  zebrafish  are  ASC  auxotrophs  and  thus  may  have  a  
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limited  amount  of  the  protective  ASC  in  muscle,  showing  an  overt  muscle  phenotype  
following  SEPN1  deficiency.  
In  order  to  test  whether  a  limited  amount  of  ASC  in  the  skeletal  muscle  of  SEPN1  KO  
mice  compromises  muscle  homeostasis  and  exacerbates   their  phenotype,  we  used  a  
mouse  model  that  resembles  the  human  condition  of  ASC  auxotrophy.  
Therefore,  mice   lacking   L-­‐Gulonolactone   oxidase   (Gulo   KO  mice),   the   enzyme  of   the  
last  step  of  ASC  biosynthesis,   that  depend  on  exogenous  vitamin  C  for  survival,  were  
crossed   with   SEPN1   KO   mice.   Two   sets   of   crosses   were   scheduled:   female   mice  
heterozygous   for  Gulo   (Gulo  Het  mice)  were   crossed  with  male  Gulo  Het  mice,   and  
female  SEPN1  KO,  Gulo  Het  mice  were  crossed  with  male  SEPN1  KO,  Gulo  Het  mice,  in  
order  to  recover  all  four  informative  genotypes  (wt,  SEPN1  KO,  Gulo  KO  and  SEPN1  KO,  
Gulo  KO  (DKO))  in  the  offspring.  The  DKO  mice  could  not  be  obtained  by  crossing  Gulo  
KO  mice  since  the  offspring  did  not  survive  the  perinatal  stage,  although  the  mothers  
were   receiving   high-­‐dosage   of   ASC   regularly   from   the   drinking  water.  Most   likely,   in  
our  mouse  model  the  ASC  concentration  in  the  milk  produced  by  the  mothers  was  not  
sufficient  for  the  pups  to  survive  the  first  days.    
Mice  with  the  double  mutant  genotype  (DKO  mice)  were  recovered  with  the  frequency  
predicted  by  the  Mendelian  transmission  of  the  mutant  alleles,  thus  indicating  the  lack  
of  any  detrimental  effect  of  both  mutations  on  prenatal  stages  (Figure  32).  
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Figure  32  -­‐  DKO  mice  were  recovered  with  the  expected  Mendelian  frequency.  SEPN1  
wt,  Gulo  Het  mice  were  crossed  with  SEPN1  wt,  Gulo  Het  mice  and  SEPN1  KO,  Gulo  Het  
mice  were  crossed  with  SEPN1  KO,  Gulo  Het  mice  and  the  offspring  genotyped  at  P14.  
The  table  indicates  the  expected  and  obtained  distribution  of  genotypes  at  weaning.  
  
Mice  lacking  GULO  need  to  be  supplemented  with  330  mg/L  of  Ascorbate  in  water  to  
thrive   and   reproduce   normally   (Maeda   et   al.,   2000).      Given   the   gender-­‐related  
differences  in  ASC  metabolism  (Nakata  and  Maeda,  2002),  male  and  female  DKO  mice  
and  Gulo   KO  mice  were   separately   randomised   to   three   different   dosages   of   ASC   in  
water  (330 mg/L  [high  dose],  110 mg/L  [medium  dose]  or  66 mg/L  [low  dose])  at  eight  
weeks   of   age,   when   the  muscle   is   fully   developed   (Figure   33).   The   aim   of   this   ASC  
titration  was  to  find  a  dose  of  ASC  that  may  reveal  signs  of  SEPN1-­‐RM  without  inducing  
the  more  serious  condition  of  scurvy  already  in  the  counterpart  of  Gulo  KO  mice.  
  
  
Figure  33    -­‐    Scheme  of  ASC  supplementation  in  mice.  
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3.1.3	  –	  ASC	  content	   in	   skeletal	  muscle	   is	  proportional	   to	   the	  dietary	   intake	  of	  
ASC	  
The  ASC   content   of   the  gastrocnemii  of   the  male   treated  mice  was  measured  by  an  
HPLC  method  already  after  one  month  of  treatment  (Figure  34)  and  was  proportional  
to   the  dietary  ASC   supplementation.  Notably,   the  gastrocnemii  of   the  mice   receiving  
the  high  dose  of  ASC  in  their  drinking  water  contained  significantly  less  of  this  vitamin  
than  those  of  the  WT  and  SEPN1  KO  mice,  thus  suggesting  that  this  dose  is  sub-­‐optimal  
(Figure  35).  
  Unfortunately,  we   failed   to  measure   reliably  ASC   in   the   serum  and   plasma  of   these  
mice  and  therefore  we  cannot  make  any  assessment  on  the  correlation  between  the  
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Figure   34   -­‐   Representative   HPLC   traces   of   the   standard   ASC   and   ASC   in   the  
gastrocnemii.   The   upper   traces   show  a   peak   signal   for   the   standard  ASC   that   is   not  
detected  in  the  mobile  phase  indicating  that  the  method  is  specific  for  the  detection  of  
ASC.  The  lower  traces  show  a  peak  signal  of  ASC  in  the  gastrocnemius  of  the  indicated  
genotypes,  that  is  absent  after  treatment  with  the  oxidant  H2O2  and  is  greatly  reduced  
after  one  week  of  ASC  starvation  in  Gulo  KO  mice.  Black  arrows  indicate  the  ASC  peak  
(elution   time   3,12   -­‐   3,25  min).   Red   arrows   indicate   the   lack   of   ASC   at   the   expected  
elution  time.  
Figure   35   -­‐   ASC   content   in   gastrocnemii.  
ASC   content   in   gastrocnemius   of   male  
mice   supplemented   with   the   three  
different   dosages   of   ASC.   Each   dot  
represents   a   single   animal   (means   ±  
standard  errors  of  the  means   (SEM),  one-­‐
way   ANOVA   test   and   Bonferroni’s   post-­‐
test,  p  values  are  indicated  on  the  graph).  
  
	  
3.1.4	  –	  Limited	  ASC	  triggers	  myopathy	  in	  SEPN1	  KO	  mice	  
The   DKO  mice   supplemented   with   the   low   dose   of   ASC   started   losing   weight   after  
three  months  and  by   the   fourth  month  had   lost  10%  of   their  original  weight.  As   the  
weight   loss   of   the  DKO  mice   treated  with   the   low  dose   of   ASC   indicated   a   selective  
effect  on  mice  with  the  SEPN1  KO  background,  all  muscles  were  examined  after   four  
months   of   treatment.   In   line   with   their   reduced   body   weight,   the   mass   of   the  
gastrocnemii  of  the  DKO  mice  treated  with  the  low  dose  of  ASC  was  reduced  by  25%.  
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In   addition,   morphometric   analysis   of   the   muscle   fibers   by   using   “wheat-­‐germ  
agglutinin”   (WGA)   staining   and   measuring   the   minimal   Feret’s   diameter   (that   is   a  
reliable  measurement  of  the  fiber  size)  showed  that  muscles  of  DKO  mice  treated  with  
the  low  dose  of  ASC  had  signs  of  atrophy  (Figure  36).      
ER   stress   response   acts   by   inhibiting   protein   translation   through   the   PERK   pathway,  
thus  analysing  the  amount  of  protein  synthesis  is  a  valid  tool  to  point  out  the  presence  
of  ER  stress  due  to  the  restricted  availability  of  ASC.  By  means  of  the   in  vivo  SUnSET  
puromycin   technique  we  were   able   to   notice   that   the   atrophy   of  DKO  mice   treated  
with   the   low   dose   of   ASC  was   also   accompanied   by   an   attenuation   of   new   protein  
synthesis  (Figure  37).  
Despite  the  lack  of  atrophy,  histochemical  staining  for  the  activity  of  the  mitochondrial  
enzyme  NADH   dehydrogenase   (NADH-­‐TR)   revealed   a   high   number   of  minicores   and  
less  NADH-­‐TR  activity   in  the  DKO  mice  treated  with  the  medium  dose  of  ASC  than   in  
the   Gulo   KO   mice,   thus   indicating   a   functional   defect   in   the   mitochondria   of   DKO  
myofibers  that  may  precede  the  atrophy  noticed  in  the  DKO  mice  treated  with  the  low  
dose  of  ASC  (Figure  38).  




Figure   36   -­‐   Low   levels   of   ASC   trigger   muscle   atrophy   in   DKO   mice.   On   the   left,  
representative   micrographs   of   gastrocnemii   stained   with   wheat-­‐germ   agglutinin  
(WGA).  On  the  right,  quantitative  measurements  of  the  average   size  of  muscle   fibers  
(minimal  Feret’s  diameter)   (µm)  and   their   frequency   in  gastrocnemii   for  n=4  muscles  
and  6000  fibers  counted  per  condition  (mean  ±  standard  error  of  the  mean)  (two-­‐tailed  










Figure  37  -­‐  Low  levels  of  ASC  affect  the  rate  of  new  protein  synthesis   in  DKO  muscle.  
Western  blotting  analysis  of  the  rate  of  new  protein  synthesis  (SUnSET  method)  in  the  
gastrocnemii   of   mice   with   the   indicated   genotype   and   ASC   treatment.   “No   Pur”  
indicates   a   control   mouse   that   was   not   injected   with   puromycin.   Puromycin  
incorporation  was  detected  with  anti-­‐puromycin  (anti-­‐Pur)  antibody,  and  GAPDH  was  
used   as   loading   control.   On   the   left,   bar   graph   shows   the   quantified   signal   of  
puromycin   in   protein   lysates   of   gastrocnemii.   Results   are   represented   as   means   ±  
standard   errors   of   the  means   (SEM)   (two-­‐tailed   unpaired   Student’s   t   test,   p   value   is  
indicated  on  the  graph)  (n=4).  




Figure  38   -­‐  A  middle  dose  of  ASC   in  DKO  muscle   is  associated  with  a  paler  NADH-­‐TR  
staining   and   the   presence   of   minicores.   Representative   NADH-­‐TR   staining   of  
gastrocnemii.  White  arrowheads  indicate  minicores  (n=6  per  group,  scale  bar:  50  µm).    
Table   indicates   the   percentage   of   minicore-­‐like   structures   in   type   I   fibers   of  
gastrocnemii  as  revealed  by  NADH-­‐TR  labelling  (average  value  from  100  type  I  fibers).  
Bar   graph   indicating   quantification   of   NADH-­‐TR   staining   reporting   for   the   NADH-­‐TR  
activity.  Results  are  represented  as  means  ±  standard  errors  of  the  means  (SEM)  for  n  =  
3  per  group  (two-­‐tailed  unpaired  Student’s  t  test,    *p  <0.05).  
In  addition,  a  lower  ASC  level  in  muscle  together  with  the  lack  of  SEPN1  increased  the  
expression   of  mRNA   of   some   ER   stress  markers   (GADD34,   BIP,   CHOP,   ATF4)   in  DKO  
mice   (as   seen  by   semi  quantitative   real   time  PCR).   Interestingly,   the   levels  of  CHOP,  
that   is  considered  a  maladaptive  mediator  of  the  ER  stress  response   in  conditions  of  
chronic  ER  stress,  are  the  highest   in  DKO  mice  fed  with  the   lowest  dose  of  ASC  thus  
suggesting   a   role   of   ASC   in   defending   ER   homeostasis   and   coping   with   the   lack   of  
SEPN1  in  muscle  (Figure  39).  









Figure   39   –   Relative   abundance   of   ER   stress   markers   mRNAs   measured   by   semi-­‐
quantitative  real-­‐time  RT-­‐PCR  in  cDNA  from  gastrocnemii  (n=3  per  each  group).  The  bar  
graphs   show  mean   values   ±SEM,   the   differences   were   examined   using   a   two-­‐tailed  
unpaired  Student’s  t-­‐test.  P  values  are  indicated  in  the  graph.  
Importantly,   the   normalized   maximal   strength   of   the   gastrocnemius   muscle  
measured  in   vivo  tended   to  be   less   in   the  DKO  mice   regardless  of   the  ASC  dose,  but  
was  significantly  less  only  in  those  treated  with  the  medium  dose  (Figure  40).  The  DKO  
muscle   of   mice   treated   with   the   lowest   dose   of   ASC   was   atrophic   and   show   only  
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  Figure   40   -­‐   A  middle   dose   of   ASC   affects  muscle   normalized   force   of  DKO  mice.   Bar  
graphs   representing   the   in   vivo   specific   force   of   the   gastrocnemius   muscle   of   the  
indicated  mice  after  four  months  of  ASC  treatment.  Please,  note  the  diminished  muscle  
force  of  the  DKO  mice  supplemented  with  the  middle  dose  of  ASC  (110  mg/L).  Results  
are  represented  as  means  ±  standard  errors  of  the  means  (SEM)  (two-­‐tailed  unpaired  












Figure   41   -­‐   A   low   dose   of   ASC   reduces   muscle   absolute   force   of   DKO   mice.   Force-­‐
frequency  curve  of  the  absolute  force  (g  stands  for  gram).     in  male  Gulo  KO  and  DKO  
mice  after  four  months  of  ASC  treatment  at  66  mg/L.  Results  are  represented  as  means  
±  standard  errors  of  the  means  (SEM)  for  n  =    12  per  group  (two-­‐way  Anova  followed  by  
Bonferroni’s  post-­‐test,  *  p<0,05).                           
     




In  this  first  part  of  my  thesis  project  we  exploited  compound  Gulo  KO  mice,  which  are  
unable  to  synthesize  ASC,  and  SEPN1  KO  mice  in  order  to  investigate  whether  reduced  
dietary   levels   of   ASC   affect   muscle   homeostasis.   The   double   mutant   mice   were  
randomized  and  fed  with  three  different  concentrations  of  ASC.  After   four  months  of  
treatment   the   hind   limb  muscles  were   analysed.   The   reported   findings   show   that   a  
deficiency   of   vitamin   C      is   associated   with   ER   stress   and   induces   a   SEPN1-­‐related  
pathological   muscle   phenotype   in  SEPN1   KO   mice,   whose   severity   is   inversely  
proportional   to   the   muscle   concentration   of   the   vitamin   C:   a   medium   dose   of   ASC  
impairs  muscle   fibers,   as   seen   by   the   formation   of   the  minicores,   and   the   impaired  
normalized  muscle   force,  whereas  a   lower  dose   triggers  a  more   serious   condition  of  
muscle  atrophy,  thus  leading  to  smaller  muscle  fibers  that  develop  less  absolute  force.  
This  investigation  regarding  the  role  of  ASC  in  SEPN1  KO  mice  was  important  to  point  
out  the  role  of  ER  stress  in  the  development  of  a  myopathic  condition  linked  with  the  
absence  of  SEPN1.  
Also,  it  could  be  useful  to  evaluate  a  potential  treatment  with  ASC  in  patients.  While  
daily  administration  of  ASC  might  not  represent  a  cure  for  the  SEPN1-­‐RM,  is  tempting  
to  assume  that  it  could  be  helpful  to  mitigate  the  symptoms.    
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3.2.1	  –	  Aim	  	  
Species   that  are  auxotrophs   for  ASC,   such  as  humans,  express  a  different  pattern  of  
transporters   for   ASC   compared   to   the   species   that   retain   the   ability   to   produce  
endogenous   ASC   (Montel-­‐Hagen   et   al.,   2008).   For   these   reasons,   one   of   the  
subsequent   steps   in   this   line   of   investigation   should   consider   an   animal  model   that  
could  resemble  even  more  closely  the  human  condition  (such  as  guinea  pigs).  
The  ASC  investigation  in  the  first  part  of  this  thesis  has  been  crucial  to  understand    that  
ER  homeostasis  is  an  important  factor  in  the  rise  of  myopathic  signs  in  SEPN1  KO  mice  
and  we  wanted  to  deepen  the  knowledge  of  this  aspect  using  a   less  complex  mouse  
model,  not  dependent  on  exogenous  ASC.  In  fact,  management  of  the  ASC  auxotrophic  
colony   was   a   task   that   required   great   effort,   due   to   constant   genotyping   of   the  
offspring  and  taking  care  of  the  preparation  of  the  vitamin  in  the  drinking  water.    
Furthermore,  diaphragm  dysfunction  has  recently  been  detected  in  paediatric  patients  
with   SEPN1-­‐RM   and   occurs   when   the   patients   are   still   ambulant   (Caggiano   et   al.,  
2017).   As   the   diaphragm   is   highly   enriched   in   mitochondria   which   are   defective   in  
SEPN1-­‐RM  patients  and   in  DKO   (Gulo  KO,  SEPN1  KO)  mice   treated  with   the  medium  
dose  of  ASC  we  decided  to  inspect  the  diaphragm  of  SEPN1  KO  mice  for  pathological  
and  ER  stress  signs.    
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3.2.2	  –	  Diaphragm	  dysfunction	  in	  older	  SEPN1	  KO	  mice	  
First  of  all,  we  examined  mRNA   levels  of  markers   (ERO1,  CHOP,  BIP,  GADD34,  ATF4,  
XBP-­‐1s)  of  the  ER  stress  and  ER  stress  response   in  the  SEPN1  KO  diaphragm  of   four-­‐
week-­‐old  mice.    At  this  stage,  there  was  a  significant  decrease  of  CHOP  and  an  increase  
of  BIP  in  the  diaphragm  muscle  of  SEPN1  KO  mice  (Figure  42).  At  twenty-­‐four-­‐week-­‐old  
there  was  a  significant  and  marked  increase  of  mRNA  levels  of  CHOP,  ERO1,  BIP,  ATF4  
and  XBP-­‐1s  in  SEPN1  KO  diaphragm  muscle  (Figure  43).  Higher  protein  levels  of  ERO1  
and   BIP  were   confirmed   in   SEPN1   KO   diaphragm  muscle   by   immunoblotting   (Figure  
43).    
Despite  the  lack  of  substantial  morphological  defects,  as  indicated  by  the  H&E  staining,  
or  fiber  type  switching,  as  indicated  by  immuno-­‐staining  with  specific  myosins  (Figure  
44),  in   SEPN1   KO   diaphragm   muscle   of   twenty-­‐four-­‐week-­‐old   mice,   ex-­‐vivo  force  
measurements   on   isolated   strips   showed   significant   impairment   in   the   normalized  
force  (not  detected  in  leg  muscles),  which  was  also  accompanied  by  a  modest  increase  
of  relaxation  time  (Figure  45).    
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Figure  42  –   Levels  of  ER   stress  markers   in  SEPN1  KO  diaphragm  of  4-­‐week  old  mice.    
Semi-­‐quantitative  real-­‐time  RT-­‐PCR  analysis  of  ER  stress  markers  of  diaphragms  from  
four-­‐week  old  mice  (means  ±  standard  errors  of  the  means  (SEM)  for  n  =  4  per  group,  
two-­‐tailed  unpaired  Student’s  t  test,  ***p  <0.001).  
  
  
Figure   43   -­‐   Lack   of   SEPN1   exacerbates   ER   stress   in   diaphragm  of   24-­‐week   old  mice.  
Semi-­‐quantitative  real-­‐time  RT-­‐PCR  analysis  of  ER  stress  markers   from  diaphragms  of  
24-­‐week   old   mice   (n=6)   (means   ±   standard   errors   of   the   means   (SEM),   two-­‐tailed  
unpaired  Student’s  t  test,  *  p<0,05,  **  p<0,01,  ***p  <0.001).  Bottom:  Immunoblots  and  
quantification  of  relative  signals  of  ERO1  and  BIP  in  diaphragm  lysates.  GAPDH  is  used  
as  a  loading  control.  
















Figure  44  -­‐  Lack  of  SEPN1  does  not   impair  muscle  morphometry.  Up:  H&E  staining  of  
WT  and   SEPN1  KO  mice   diaphragm.  Middle:  minimal   Feret’s   diameter   (µm)   (n=1200    
total   fibers   from   3   different   animals   for   each   genotype)   of  WT   and   SEPN1   KO  mice  
diaphragms.  Bottom:   fiber   type   immunostaining   images  of  diaphragms  using   specific  
myosin  heavy  chain  antibodies  (scale  bars  =  100  µm).  
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Figure   45   –   Contractile   diaphragm  dysfunction   in   SEPN1  KO  mice.   Frequency   curves,  
tetanic   force  and  half   relaxation   time   (stimulation   frequency  at  100  Hz)  observed   in-­‐
vivo  in  the  gastrocnemii  (left  half  of  the  panel)  (n=12)  and  ex-­‐vivo  in  diaphragm  strips  
(right   half   of   the   panel)   (n=20)   (means   ±   SEM,   two-­‐tailed   unpaired   Student’s   t   test,  
***p  <0.001).    
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3.2.3	  –	  Ablation	  of	  CHOP	  rescues	  diaphragm	  impairment	  in	  SEPN1	  KO	  mice	  
It   was   shown   recently   that   the   genetic   deletion   of   the   ER   stress   mediator   CHOP  
preserves  tissue  function  after  a  chronic  ER  stress  (Marciniak  et  al.,  2004;  Pennuto  et  
al.,   2008;   Song   et   al.,   2008).   CHOP   is   a   pro-­‐apoptotic   gene   that   is   activated   due   to  
persistent  and  unresolved  ER  stress  by  the  UPR  program  (Ron  and  Walter,  2007).  CHOP  
KO  mice  don’t  show  any  pathological  phenotype,  and  they  don’t  differ  from  wild  type  
in  terms  of  lifespan,  fertility  and  thriving  ((Zinszner  et  al.,  1998).      
Inspired  by  these  studies  we  decided  to  test  whether  CHOP  ablation  is  also  beneficial  
to   SEPN1   KO   muscle.   To   this   purpose   CHOP   KO   mice   (Zinszner   et   al.,   1998)   were  
crossed  with   SEPN1   KO  mice,   and   diaphragm   function   tested   in  mice  with   the   four  
informative  genotypes:  WT,  CHOP  KO,  SEPN1  KO,  and  double  SEPN1/CHOP  KO  (DKO)  
mice.  The  contemporary  deletion  of  CHOP  and  SEPN1  lowered  ERO1  mRNA  levels  and  








Figure   46   -­‐   Deletion   of   CHOP   in   mice   lacking   SEPN1   decreases   ER   stress.   Semi-­‐
quantitative   real-­‐time  RT-­‐PCR  of   ER   stress   response  markers   in  mRNA  obtained   from  
WT,  SEPN1  KO,  CHOP  KO  and  DKO  mice  diaphragms  (n=8)  (means  ±  standard  error  of  
the  mean  (SEM),  one-­‐way  ANOVA  multiple  comparison  test  and  Sidak’s  post  test,  **p  
<0.01,  ***p  <0.001).  
As  one  consequence  of  ER  stress  is  the  attenuation  of  protein  synthesis,  we  examined  
the   levels   of   protein   translation   in   the   diaphragms  of  WT,   CHOP  KO,   SEPN1  KO   and  
DKO  mice  by  injecting  puromycin  in  mice  and  using  the  SUnSET  puromycin  assay.  The  
results   of   this   assay   show   that   the   rate   of   protein   synthesis  was   lower   in   SEPN1  KO  
diaphragms  when  compared  to  the  WT  and  restored  in  DKO  mice  (Figure  47).  
Figure   47   -­‐   Deletion   of   CHOP   rescues  
the   impaired   protein   synthesis   in  
diaphragms   of   SEPN1   KO   mice.  
Immunoblot   and   quantification   (with  
arbitrary   units)   of   puromycin-­‐tagged  
proteins  (newly  synthesised  proteins)  in  
WT,  SEPN1  KO,  CHOP  KO  and  DKO  mice  
diaphragm.   Below,   it   is   shown   a  
ponceau   (Protein)   of   the   loaded  
proteins.  “Co-­‐”  indicates  a  control  mice  
not   injected  with  puromycin.   (means  ±  
standard  error  of  the  mean  (SEM),  one-­‐
way   ANOVA   multiple   comparison   test  
and  Sidak’s  post  test,  **p  <0.01).  
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Importantly,  ex   vivo  measurements   of   diaphragm   force   of  WT,   CHOP  KO,   SEPN1  KO  
and  DKO  mice  show  a  significant  recovery  of  this  force  in  the  DKO  mice  indicating  that  
the   deletion   of   CHOP   in   a   SEPN1  KO  diaphragm   improves  muscle   physiology   (Figure  
48).  
  
Figure  48  -­‐  Deletion  of  CHOP  
in   mice   lacking   SEPN1  
rescues   diaphragm  
dysfunction.   Representative  
force   frequency   curves   and  
below  bar  graphs  of  tetanic  
force   of   ex-­‐vivo   diaphragm  
strips   from  WT,   SEPN1   KO,  
CHOP   KO   and   DKO   mice  
(n=8)   (means   ±   standard  
error   of   the   mean   (SEM),  
one-­‐way   ANOVA   multiple  
comparison  test  and  Sidak’s  
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3.2.4	   –	   Ablation	   of	   CHOP	   reduces	   exercise-­‐‑induced	   ER	   stress	   in	   SEPN1	   KO	  
muscle	  	  
Although  we   and   others   have   shown   that   the   hind   limb  muscles   of   SEPN1  KO  mice  
have   no   gross   alterations   in  muscle   histology,   physiology   or   in   the   levels   of   the   ER  
stress   markers,   we   reasoned   that   SEPN1   function   may   be   important   when   activity  
levels   rise   during   muscle   activity.   Therefore,   we   investigated   the   expression   of   the  
mRNA  of   the   ER   stress  markers   in   soleus   and   gastrocnemius  muscles   (two  different  
hind   limb   muscles)   isolated   from   mice   after   exhaustive   running,   during   which   the  
muscle  contractile  activity  significantly   increases  (Wu  et  al.,  2011).  ER  stress  markers  
(ERO1,  BIP,  XBP-­‐1s,  ATF4  and  GADD34)  were  more  upregulated  after  running  in  SEPN1  
KO  soleus,  that  is  an  oxidative  muscle,  when  are  compared  to  those  of  the  WT.  Milder  
differences  in  the  levels  of  ER  stress  markers  were  also  seen  in  the  gastrocnemius,  that  
is   mainly   a   glycolytic   muscle.   Interestingly,   ERO1   levels,   and   those   of   the   other   ER  






























Figure  49  -­‐  Deletion  of  CHOP  reduces  ER  stress  in  the  soleus  of  SEPN1  KO  mice  after  an  
intensive   bout   of   exercise.      Semi-­‐quantitative   Real-­‐time   RT-­‐PCR   analysis   of   ER   stress  
markers  in  mRNA  obtained  from  soleus  of  24-­‐week  old  sedentary  (rest)  and  exhausted  
(run)   mice   (means   ±   standard   error   of   the   mean   (SEM),   one-­‐way   ANOVA   multiple  
comparison  test  and  Sidak’s  post  test,  *p  <0.05,  **p<0.01,  ***p  <0.001).  
  
  



















Figure  50  -­‐  Deletion  of  CHOP  reduces  ER  stress  in  the  gastrocnemius  of  SEPN1  KO  mice  
after  an   intensive  bout  of  exercise.  Semi-­‐quantitative  Real-­‐time  RT-­‐PCR  analysis  of  ER  
stress   response   markers   in   mRNA   obtained   from   WT,   SEPN1   KO   and   DKO  
gastrocnemius   of   24-­‐week   old   sedentary   (rest)   and   exhausted   (run)   mice   (means   ±  
standard   error   of   the   mean   (SEM),   one-­‐way   ANOVA   multiple   comparison   test   and  
Sidak’s  post  test,  *p  <0.05,  **p<0.01,  ***p  <0.001).  
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3.2.5	  –	  Conclusions	  
The  reason  for  a  major  effect  of  SEPN1  deficiency  on  the  diaphragm  and  the  relative  
preservation  of  the  leg  muscle  is  still  object  of  study,  but  likely  it  is  related  to  the  high  
oxidative  metabolism  of  the  diaphragm  in  addition  to  its  increased  activity.  SEPN1  KO  
mice  resemble  the  phenotype  of  patients  with  SEPN1-­‐RM,  insofar  as  they  do  not  show  
major  myopathic  signs  at  the  level  of  the  leg  muscles  under  normal  cage  conditions  but  
the  force  of  the  diaphragm  muscle  is  impaired.  This  correlates  with  higher  levels  of  ER  
stress  markers  CHOP  and  its  target  ERO1.  
Therefore,  we  investigated  whether  the  ER  stress  mediator  CHOP  is  involved  in  SEPN1  
KO  muscle   phenotype   by   crossing   SEPN1   KO  with   CHOP   KO  mice   and   analysing   the  
muscle   phenotype   of   the   compound   mutant   mice.   The   ablation   of   CHOP   restored  
diaphragm   function   in   SEPN1   KO   mice,   indicating   that   the   CHOP   branch   of   the   ER  
stress  response  is  an  important  pathogenic  cause  in  SEPN1  KO  mice.  
In  the  end,  the  deletion  of  CHOP   limited  the  activation  of  the  maladaptive  branch  of  
the  UPR  and   the  activation  of   the  apoptotic  program   in   the  DKO  mice,   relieving   the  
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3.3.1	  -­‐‑	  Aim	  
Autosomal  recessive  mutations  of  the  SEPN1  gene  cause  SEPN1-­‐RM,  a  rare  congenital  
myopathy   typically  associated  with   insulin   resistance.   In   the   third  part  of  my  project  
thesis  we   investigated   the  mechanisms   that   are   involved   in   the   development   of   the  
insulin  resistance  in  SEPN1-­‐devoid  models.  Specifically,  we  pursued  the  hypothesis  that  
insulin   resistance   may   be   triggered   by   the   augmented   ER   stress   due   to   lipid  
accumulation  in  skeletal  muscle  of  SEPN1  KO  mouse.  
3.3.2	  –Palmitate-­‐‑induced	  ER	  stress	  in	  SEPN1	  devoid	  myotubes	  	  
Insulin  resistance  has  been  already  connected  to  the  accumulation  of  lipid  droplets  in  
skeletal   muscle   (Unger   and   Scherer,   2010).   Furthermore,   overload   of   palmitate,   a  
saturated  fatty  acid,  has  been  reported  to  generate  ER  stress  in  myotubes,    although  
the  mechanisms   underlying   this   connection   remain   unclear   (Perry   et   al.,   2018).   For  
these   reasons,   we   decided   to   start   testing   the   effect   of   palmitate   on   SEPN1-­‐devoid  
myotubes.  In  order  to  avoid  cellular  adaptation  issues,  we  decided  to  work  with  C2C12  
myotubes  where  an  acute  knock  down  of  SEPN1  (by  an  adenovirus  that  delivers  SEPN1  
shRNA)   was   triggered   and   compare   these   myotubes   with   mock-­‐infected   isogenic,  
except   for   SEPN1,   WT   myotubes.   Three   days   after   adenoviral   infection,   semi-­‐
quantitative  real  time  RT-­‐PCR  showed  that  mRNA  SEPN1  levels  were  70%  lower  when  
compared   to   WT   cells.   Unfortunately,   the   polyclonal   antibody   that   we   used   to  
recognize  SEPN1  (SAB210211,  SIGMA)  suddenly  stopped  working  and  thus  we  have  to  
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rely  only  on  the  RT-­‐PCR  data  to  estimate  SEPN1  expression  levels.    To  assess  whether  
lipid  accumulation  affects  the  viability  of  the  cells,  WT  and  SEPN1  KD  C2C12  cells  were  
exposed   to   palmitate   at   concentrations   between   5   and   500   μM   or   its   vehicle.   The  
colorimetric  viability  MTS  assays  showed  that  SEPN1  KD  cells  were  less  viable  than  WT  
cells   at   concentration   of   palmitate   higher   than   50   µM,   which   suggests   a   greater  
lipotoxicity  of  palmitate  in  SEPN1  KD  cells  (Figure  51).  
Figure  51  -­‐  SEPN1  defends  myotubes  
from   the   consequence   of   a   lipotoxic  
stimulus.  Metabolic  activity   (MTS)  of  
WT   and   SEPN1   KD   C2C12 cells  
treated   with   the   indicated  
concentrations  of  palmitate  for  24 h.  
Metabolic   activity   is   expressed   as   the   relative   reduction   in  MTS   signal   in   palmitate-­‐
exposed  cells  compared  to  that  of  vehicle-­‐treated  cells   (arbitrarily  set  at  100%)  (n= 4)  
(means  ±  standard  error  of  the  mean  (SEM),  two-­‐way  ANOVA  multiple  comparison  test  
and   Sidak’s   post   test,   *p   <0.05)   (this   experiment  was   done   in   collaboration  with  my  
labmate  Ersilia  Varone).  
In  order  to  determine  whether  the   lower  viability   induced  by  palmitate   in  SEPN1  KD  
myotubes   is   due   to   increased   ER   stress,  we   examined   the  mRNA   levels   of   ER   stress  
markers   in   WT   and   SEPN1   KD   cells   after   challenging   the   cells   with   the   two  
concentrations   of   palmitate   of   100   and   200   µM.   Interestingly,   the   levels   of   the   ER  
stress  markers  CHOP,  ERO1,  GADD34,  ATF4  and  BIP  were  increased  in  SEPN1  KD  cells  
challenged  with  both  concentrations  of  palmitate,   thus  indicating   increased  ER  stress  
in  SEPN1  KD  cells  (Figure  52).    





















Figure   52   -­‐   Lack   of   SEPN1   and   palmitate   treatment   trigger   ER   stress   in   C2C12   cells.  
Semi-­‐quantitative  Real-­‐time  RT-­‐PCR  analysis  of  ER  stress  markers  in  mRNA  of  WT  and  
SEPN1  KD  cells  treated  with  BSA  (vehicle  condition)  or  palmitate  at  the  concentrations  
of  100  µm  or  200  µm   (means  ±   standard  error   of   the  mean   (SEM),  one-­‐way  ANOVA  
multiple   comparison   test   and   Sidak’s   post   test,   **p   <0.01,   ***p<0,001)   (this  
experiment  was  done  in  collaboration  with  my  labmate  Ersilia  Varone).  
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3.3.3	  –	  Lipotoxicity	  affects	  insulin	  sensitivity	  in	  SEPN1	  devoid	  myotubes	  	  
As  ER  stress  may  affect  insulin-­‐dependent  glucose  uptake  (Panzhinskiy  et  al.,  2013)  we  
investigated  whether  SEPN1  deficiency  increases  the  susceptibility  to  insulin  resistance  
of   myotubes.   To   this   end,   WT   and   SEPN1   KD   myotubes   were   tested   for   insulin-­‐
dependent  glucose  uptake   in  the  presence  of  vehicle  or  palmitate  (100  µM)  by  using  
metabolic   tracings   of   H3-­‐2-­‐deoxyglucose   (2DG).   As   expected   WT   and   SEPN1   KD  
myotubes   showed   reduced   uptake   of   2DG   following   palmitate   treatment   when  
compared  to  the  vehicle-­‐treated  counterpart  but  the  uptake  of  2DG  was  less  in  SEPN1  
KD   than   in   WT   suggesting   that   SEPN1   deficiency   significantly   contributes   to   the  
impairment  of  the  insulin-­‐mediated  glucose  uptake  (Figure  53).  
Figure   53   -­‐   SEPN1   KD   C2C12   cells   treated  
with   palmitate   are   less   responsive   to  
insulin-­‐dependent  glucose  uptake.  Dot  blots  
representing   the   percentage   increase   of  
glucose   uptake   in   the   insulin   -­‐treated  
groups   compared   to   the   untreated  
counterpart   (n=4)   (means  ±  standard  error  
of   the   mean   (SEM),   one-­‐way   ANOVA  
multiple   comparison   test   and   Sidak’s   post  
test,  ***p  <0.001).           
           
3.3.4	  –High-­‐‑	  fat	  fed	  SEPN1	  KO	  mice	  are	  insulin	  resistant	  and	  myopathic	  
In  order  to  study  the  direct  consequences  of  fatty  acid-­‐induced  lipotoxicity  on  SEPN1  
KO  skeletal  muscle,  we  fed  9-­‐week-­‐old  adult  male  WT  and  SEPN1  KO  mice  a  high-­‐fat  
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diet   (HFD,   40%   of   calories   from   fat)   for   nine  weeks   and   compared   them  with   their  
counterparts  fed  a  standard  diet.    
The  WT  and  SEPN1  KO  mice   fed   the   standard  diet   showed  no   statistically   significant  
difference  in  weight  gain,  but  the  SEPN1  KO  mice  on  HFD  showed  a  tendency  to  gain  
less  weight  even  though  their   food   intake  was  similar  to  that  of  the  WT  mice  (Figure  
54).  Glucose   tolerance   tests   showed   that  glycemic   control  was   comparable  between  
WT  and  SEPN1  KO  on   standard  diet  but,  despite   the   lower  weight  gain  of   SEPN1  KO  
mice  on  HFD,   these  mice  displayed  moderately  greater  glucose   intolerance   than   the  
WT  mice  (Figure  55).  
Figure  54  -­‐  Body  weight  of  standard  and  HFD  fed  WT  and  SEPN1  KO  mice.  Body  weight  
of  WT  and  SEPN1  KO  mice  under  standard  diet   (left  panel)   (n=5)  or  HFD  (right  panel)  
(n=6)  for  9  weeks  (means  ±  standard  error  of  the  mean  (SEM).  
  
  
     
87  
  
Figure  55  –  Higher  glucose  intolerance  in  HFD  fed  SEPN1  KO  mice.  Left:  Blood  glucose  
trace  of  GTTs   in  WT  and  SEPN1  KO  mice  fed  a  standard  diet   (n=5)  or  a  HFD  (n=6)   for  
nine  weeks.  The  time-­‐points  represent  the  times  of  15,  30,  60,  120  and  180  min  after  
the  intraperitoneal  injection  of  glucose.  Right:  bar  graphs  of  the  Area  Under  the  Curve  
(AUC)   of   the   glycemic   curve   (means   ±   standard   error   of   the   mean   (SEM),   two-­‐way  
ANOVA  multiple  comparison  test  and  Sidak’s  post-­‐test,  **p  <0.01,  ****p<0,  0001).     
  
This   modest   impairment   of   SEPN1   KO   glucose   tolerance   was   not   associated   with   a  
decrease   in   plasma   and   pancreatic   insulin   levels   thus   suggesting   that   the   defective  
glucose  tolerance  of  the  SEPN1  KO  mice  was  not  due  to  defects  in  insulin  secretion  by  
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Figure   56   -­‐   HFD   and   lack   of   SEPN1   do   not   impair   insulin   secretion.   Left:   bar   graphs  
representing  insulin  levels  in  the  plasma  of  WT  and  SEPN1  KO  mice  fed  a  regular  diet  
(n=5)   or   a   HFD   (n=6)   for   nine   weeks.   Right:   bar   graphs   showing   insulin   levels   in  
pancreatic  lysates  of  the  previously  described  experimental  groups  (means  ±  standard  
error  of   the  mean   (SEM),  one-­‐way  ANOVA  multiple   comparison   test  and  Sidak’s  post  
test,  *p<0,05,  **p  <0.01).  
Subsequently,   given   the   correlation   between   ER   stress   and   insulin   resistance,   we  
analysed   the   mRNA   levels   of   ER   stress   markers   in   the   gastrocnemius   muscle.   In  
qualitative  agreement  with  our  findings  in  palmitate-­‐treated  SEPN1  KD  myotubes,  the  
levels  of  ER  stress  markers  CHOP,  ERO1  and  GADD34  were  higher  in  the  gastrocnemii  
of  the  SEPN1  KO  mice  fed  a  HFD  (Figure  57).    
Despite   these   defects,   the   gastrocnemius   of   the   SEPN1   KO  mice   fed   a   HFD   did   not  
show  significant  alterations  in  H&E  staining  but  the  NADH-­‐TR  staining,  that  reports  for    
oxidative   activity,   as  well   as   the   PAS   staining,   that   reports   for   glycogen   levels,  were  
paler.  On   the   contrary,  Oil   Red  O   staining   showed   an   increase/accumulation   in   lipid  
droplets  of  high-­‐fat-­‐fed  SEPN1  KO  gastrocnemius  (Figure  58).    

























Figure  57  -­‐  HFD  and  lack  of  SEPN1  enhance  ER  stress.  Semi-­‐quantitative  real-­‐time  RT-­‐
PCR   analysis   of   ER   stress  markers   from  WT   and   SEPN1   KO  mice   gastrocnemii   fed   a  
regular  diet  (n=5)  or  a  HFD  (n=6)  (means  ±  standard  error  of  the  mean  (SEM),  one-­‐way  





















Figure  58   -­‐   Lack  of   SEPN1   together  with  HFD   triggers  accumulation  of   lipids,   reduces  
oxidative  activity  and  glycogen  in  muscle.  Representative  H&E,  Oil  Red  O  (ORO),  NADH-­‐
TR  and  periodic  acid-­‐Schiff  (PAS)  stainings  in  WT  and  SEPN1  KO  gastrocnemii  from  mice  
fed  a  standard  (up)  or  HFD  (below)  diet.  Scale  bar  40  µm  (below,  20  µm  for  the  high  
magnification  acquisitions)   (n=4)   (this  experiment  was  done   in   collaboration  with  my  
labmate  Simona  di  Modica).  
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The  similar  weight  between  gastrocnemii  of  HFD  fed  WT  and  SEPN1  KO  indicated  lack  
of  atrophy  in  the  SEPN1  KO  muscle.    
Despite  lack  of  atrophy  in  the  HFD  fed  SEPN1  KO  muscle,  the  force  was  depressed  and  
the   force  generated  was   significantly   less  during   tetanic   stimulation   (100  Hz)   (Figure  
59).    
  
Figure   59   -­‐   Lack   of   SEPN1   together  with  
HFD   impair   skeletal   muscle   force.                              
Up:  dot  plot  of  the  weight  of  gastrocnemii  
from  mice  fed  a  chow  normal  diet  and  a  
HFD.    
Middle:   normalized   force/frequency  
graph   of   hind   limb   muscle   (that   mainly  
reports   for   the   force   of   the  
gastrocnemius)  in  the  indicated  groups.    
Bottom:     Bar  graph  of  the  tetanic   in-­‐vivo  
force  (stimulation  frequency  of  100  Hz)  in  
the   indicated   groups   (means   ±   standard  
error   of   the   mean   (SEM),   one-­‐way  
ANOVA   multiple   comparison   test   and  
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3.3.5	  –	  Conclusions	  
ER  stress  can  be  activated  by  a  saturated  fatty  acid  overload  that  is  also  linked  to  the  
insulin   resistance.  We  have  explored   the  hypothesis   that  SEPN1  deficiency   sensitizes  
muscle  cells  to  the  consequences  of  ER  stress  and  therefore  increases  the  lipotoxicity  
of   saturated   fatty   acids   impairing   insulin   sensitivity.   We   have   seen   that   SEPN1  
deficiency  increases  palmitate-­‐induced  lipotoxicity,  thus  eliciting  ER  stress  and  blunting  
insulin-­‐dependent  glucose  uptake  in  myotubes.    
SEPN1  KO   triggers  glucose   intolerance   in  mice  on  a  HFD  despite   their   trend   towards  
gaining  less  weight  than  their  WT  counterparts  but  no  overt  abnormalities  in  plasma  or  
pancreatic   insulin   content  were   detected,   suggesting   that   the   glucose   intolerance   is  
not  caused  by  a  defect  in  endocrine  pancreatic  insulin  secretion.    
In  qualitative  agreement  with   findings   in  SEPN1-­‐devoid  myotubes,  HFD   in  SEPN1  KO  
mice   leads   to   chronic   ER   stress   in   muscle,   which   suggests   a   correlation   between  
reduced  body  glucose  tolerance,  insulin  activity  and  increased  ER  stress  in  the  muscles  
of   SEPN1   KO   mice   fed   a   HFD   (Figure   60).   These   abnormalities   in   SEPN1   KO   mice  
triggered   by   a   HFD   reduce   hind   limb   skeletal   muscle   strength,   which   is   instead  
preserved  in  these  mice  fed  a  standard  chow  diet.  Therefore,  we  propose  a  model  in  
which  the  lack  of  SEPN1  sensitizes  skeletal  muscle  to  the  consequences  of  chronic  ER  
stress  induced  by  palmitate  treatment  in  cells  or  a  HFD  in  mice,  thus  impairing  insulin  
signalling   and   affecting   force-­‐frequency   responses   in   skeletal   muscle.   What   is  
therapeutically   important   is   that   these   findings   suggest   that   environmental   cues  
eliciting  ER  stress  in  skeletal  muscle  (such  as  HFD)  affect  the  pathological  phenotype  of  
SEPN1-­‐RM,   and   can   therefore   contribute   beyond   simple   genotype-­‐phenotype  
correlations  to  the  prognosis  of  SEPN1-­‐RM  patients.  
  











Figure   60   –   Lack   of   SEPN1   impairs   muscle   force.   Without   SEPN1,   fatty   acids  
accumulation  (either  caused  by  palmitic  acid  or  HFD)  triggers  a  chronic  ER  stress  that  
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SEPN1-­‐RM  is  a  rare  congenital  disorder  arising  from  loss-­‐of-­‐function  mutations  in  the  
SEPN1  gene   that  affects   the  muscle   system,  and   leads   to   life-­‐threatening   respiratory  
malfunction,   requiring  assisted  ventilation  with   relative  preservation  of   limb  muscles  
and  ambulation.  No  FDA-­‐approved  drugs  are  available  for  SEPN1-­‐RM,  so  clarifying  its  
pathogenic   mechanism   is   an   important   step   towards   developing   a   pharmacological  
treatment.  
SEPN1  KO  mice  are  somehow  protected  from  the  effects  of  SEPN1   loss  as  they  don’t  
show   an   overt   muscle   phenotype.   This   suggests   the   existence   of   factors   that  
compensate   for   the   lack   of   SEPN1   in   the   murine   muscle   and   leads   us   to   test   the  
hypothesis  that  the  well  placed,  ER  resident,  ASC  may  contribute  to  this  compensation.  
We   therefore   analysed   the   hind   limb   muscle   phenotype   of   the   offspring   from   the  
crosses   between   Gulo   KO   mice,   unable   to   synthesize   ASC,   and   SEPN1   KO   mice   to  
investigate  whether   reduced   dietary   levels   of   ASC   affect  muscle   homeostasis   of   the  
SEPN1  KO  mouse.  Our  findings  demonstrate  that,  by  inducing  ER  stress,  a  deficiency  of  
vitamin  C  induces  a  SEPN1-­‐related  pathological  muscle  phenotype  in  SEPN1  KO  mice,  
whose  severity  is  inversely  proportional  to  the  muscle  concentration  of  the  vitamin:  a  
medium  dose  of  ASC  impairs  muscle  fibers,  as  seen  by  the  presence  of  minicores,  and  a  
reduced   normalized   muscle   force,   whereas   a   lower   dose   triggers   the   more   serious  
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muscle   atrophy,   thus   leading   to   smaller  muscle   fibers   and   reduced   absolute  muscle  
force.   This   part   of   the   project   was   very   informative   not   only   to   understand   that  
deficiency  of  an  anti-­‐oxidant  vitamin  unveils  the  muscle  phenotype  in  SEPN1  KO  mice  
but  also  to  reveal  features  of  chronic  ER  stress  in  the  SEPN1  KO  muscle  that  can  be  an  
important  part  of  the  pathogenic  mechanism  of  SEPN1-­‐RM.    
From  a  therapeutic  point  of  view,  it  would  be  interesting  to  administer  daily  dosages  of  
ASC  to  SEPN1-­‐RM  patients,  in  order  to  evaluate  if  the  antioxidant  action  of  ASC  could  
ameliorate   the   symptoms   of   the   disease   also   in   human.  While   this   treatment   looks  
promising,   it’s   necessary   to   first   deepen   the   knowledge   of   ASC   bioavailability  
depending   on   the   type   of   administration.   Oral   administration,   in   fact,   should   be  
avoided  since  the  majority  of  ASC  would  be  absorbed  by  the  gastro-­‐intestinal  tract  and  
could   not   reach   the   skeletal   muscles.   Thus,   in   a   possible   clinical   trial,   Intravenous  
administration  should  be  preferred.  
In   the   second   part   of   the   thesis   project   we  moved   from   the   double  mutant   GULO,  
SEPN1   KO   mice,   to   a   simpler   model   –   a   mouse   model   that   didn’t   require  
genotypization   of   the   offspring   and   almost   daily   preparation   of   the   ASC   enriched  
drinking   water   -­‐   in   order   to   acquire   expertise   in   the   phenotypical   analysis   of   the  
diaphragm.   The   collaboration   with   the   laboratory   of   Prof.   Bert   Blaauw   and   Prof.  
Stefano   Schiaffino   at   the   University   of   Padua,   two   experts   in   phenotypical  
characterisation  of  diaphragm,  was  instrumental  to  lead  me  to  pinpoint  a  pathological  
phenotype  of  the  diaphragm  in  adult  SEPN1  KO  mice.  Although  signs  of  atrophy  were  
missed,  reduced  protein  synthesis  together  with  chronic  ER  stress  were  clear  features  
of   SEPN1  KO  diaphragms.   Importantly,   the   force   of   the  muscle   strips   of   diaphragms  
following   electrical   stimulation   was   impaired   indicating   a   defective   mechanism   of  
excitation-­‐contraction   coupling   in   SEPN1   KO   diaphragm.   Given   the   higher   levels   of  
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CHOP,   a   maladaptive   ER   stress   mediator   in   conditions   of   chronic   ER   stress,   in   the  
diaphragm   of   SEPN1   KO   mice   we   decided   to   proceed   with   a   genetic   approach   by  
crossing  CHOP  KO  and  SEPN1  KO  mice  and  to  test  whether  the  lack  of  CHOP  rescues  
the   pathological   phenotype   of   SEPN1  KO  diaphragm  by   attenuating   ER   stress.   CHOP  
loss  attenuated  ER  stress  and   improved  the  contractile   function  of  the  diaphragm  of  
SEPN1  KO  mice  suggesting  that  ER  stress  is  an  important  component  of  the  pathogenic  
mechanism   underlying   SEPN1-­‐RM.   The   lack   of   CHOP   avoids   the   activation   of   the  
maladaptive   branch   of   the   UPR   and   the   pro-­‐apoptotic   program,   sorting   a   beneficial  
effect  in  the  SEPN1  KO  mice,  whose  diaphragm  activity  would  otherwise  be  impaired.  
Finally,  in  an  attempt  to  dissect  the  mechanism  behind  the  insulin  resistance  of  SEPN1-­‐
RM  patients  we  reasoned  to  test  whether  HFD,  that  triggers  insulin  resistance  and  ER  
stress   in   skeletal   muscle,   induced   myopathy   in   the   otherwise   protected   hind   limb  
muscles  of  SEPN1  KO  mice.  
We  saw  that  SEPN1  deficiency  impairs  glucose  tolerance  and  leads  to  exaggerated  ER  
stress  and  reduced  hind  limb  skeletal  muscle  strength  in  SEPN1  KO  mice  fed  a  HFD.    
These   findings   allowed  us   to   propose   a  model   in  which   the   lack   of   SEPN1   sensitises  
skeletal   muscle   to   the   consequences   of   chronic   ER   stress   induced   by   palmitate  
treatment  in  cells  or  HFD  in  mice,  thus  impairing  insulin  signalling  and  affecting  force-­‐
frequency  responses  in  skeletal  muscle.    
Our   hypothesis   is   that   SEPN1   protects   the   cells   and   the   skeletal   muscle   from   the  
development   of   ER   stress   due   to   a   lipotoxic   environment,   although   the  mechanism  
underlying  this  protection  is  still  unclear  and  needs  to  be  further  addressed.  
What  is  therapeutically  important  is  that  HFD,  by  eliciting  ER  stress  in  skeletal  muscle,  
affects  the  pathological  phenotype  of  SEPN1-­‐RM,  and  can  therefore  contribute  beyond  
simple  genotype-­‐phenotype  correlations  in  establishing  a  prognosis.  
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In  this  perspective,  these  results  will   lead  to  the   intriguing  idea  of  testing  drugs  as  4-­‐
PBA   (4-­‐phenylbutiric   acid)   and   TUDCA   (Tauroursodeoxycholic   acid),   two   chemical  
chaperones,  which  are  involved  in  attenuating  ER  stress  and  are  already  FDA  approved,  
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Procedures   involving   animals   were   conducted   in   conformity   with   the   institutional  
guidelines   at   the   IRCCS   –   Mario   Negri   Institute   for   Pharmacological   Research   in  
compliance  with  national  (D.lgs  26/2014;  Authorization  n.  19/2008-­‐A  issued  March  6,  
2008  by  Ministry  of  Health)  and  international  laws  (EEC  Council  Directive  2010/63/UE;  
the  NIH  Guide  for  the  Care  and  Use  of  Laboratory  Animals,  2011  edition).  They  were  
reviewed   and   approved   by   the  Mario   Negri   Institute   Animal   Care   and   by   an   Ethical  
Committee  that  includes  ad  hoc  members  for  the  judgement  of  ethical  issues,  and  by  
the  Italian  Ministry  of  Health  (Decreto  no.  381/2016-­‐PR  and  485/2018-­‐PR).    
SEPN1   KO   mice   were   purchased   from   EMMA   repository,   GULO   KO   from   MMRC  
repository   and   CHOP   KO   mice   from   Jackson   laboratory.   DNA   preparation   for   PCR  
genotyping:  partial  mice  phalanx  (from  pups  until  10-­‐14  days  of  age)  or  tail  tips  were  
lysed  overnight  in  a  mix  composed  of  Direct  PCR  lysis  reagent  (Viagen)  and  proteinase  
K  (SIGMA,  P8044)  0,2  mg/mL,  in  a  thermomixer  at  55°C  with  shake.  The  day  after,  to  
inactivate   the  proteinase  K,   the   temperature  was   raised  at  85  C   for  15  minutes  and  
finally  the  samples  stored  at  4°C.    
Sepn1  locus  genotyping  protocol  
A   PCR   mix   was   prepared   by   mixing   SEPN1   Forward   primer   (5’–3’):  
TCCAATGACGTCAGGCTGTGACTTGC,   SEPN1   Reverse   primer   (5’-­‐3’):  
GGATCAGTAGAAAGTACC        primers  at  a  final  concentration  of  0,35  µM,  Quickload  Taq  
2x   master   mix   (New   England   Biolabs,   M0271S)   and   the   tissue   lysate   that   contains  
genomic  DNA  (1  µl).  
The  PCR  cycle  as  follows:  94°C  for  2  minutes,  94°C  for  30  seconds,  56°C  for  30  seconds,  
72°C   for   1   minute,   repeat   from   step   2   to   4   for   35   times,   final   step   at   72°C   for   5  
minutes.  Horizontal  gel  electrophoresis  was  used  to  run  the  amplicons  (1,5%  agarose  
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gel  with  0,3X  Gel  Red  Nuclease  Acid  staining  as  a  DNA-­‐binding  dye),  for  25  minutes  at  
100  V  that  were  visualized  by  using  an  UV  transilluminator  (Figure  61).    
  
Figure   61   –   Representative   snapshot   of   an   agarose   gel   with   the   amplicons   of   the  
genotype   of   Sepn1   locus   of   11   different   pups.   “C-­‐”   refers   to   a   blank,   i.e.   a   sample  
without   template   DNA,   C(HET)   refers   to   a   sample   from   an   already   known   Sepn1  
heterozygous  mouse,   C(WT)   from  a  known   Sepn1  wild-­‐type  mouse   and   C(KO)   from  a  
known  SepN1  KO  mouse.  M  1  kbp  is  a  DNA  ladder  (New  England  Biolabs  –  N0468S).  
  
L-­‐Gulonolactone  oxidase  locus  genotype  protocol  
GULO  wild  type  and  GULO  knock  out  allele  had   to  be  amplified   in  two  different  PCR  
reactions  with  the  same  reagents  of  above.    
The   primer   used  were:  GULO   Forward   primer   (common)   (5’–3’):   GTC  GTG  ACA  GAA  
TGT  CTT  GC,    
GULO   wild   type   reverse   primer   (5’-­‐3’):   CCC   AGT   GAC   TAA   GCA   TAA   GC,   GULO   KO  
reverse  primer  (5’-­‐3’):  CGC  GCC  TTA  ATT  AAG  GAT  CC.  The  PCR  cycle  as  follows:  94°C  
for   2  minutes,   94°C   for   30   seconds,   55°C   for   30   seconds,   72°C   for   1  minute,   repeat  
from  step  2  to  4  for  35  times,  final  step  at  72°C  for  5  minutes  (Figure  62).  












Figure   62   –   Representative   snapshot   of   an   agarose   gel   with   the   amplicons   of   the  
genotype  of  Gulo  locus  of  12  different  pups.  Gulo  WT  and  KO  alleles  had  to  be  amplified  
in  two  different  reactions.  “C-­‐”  refers  to  a  blank,  i.e.  a  sample  without  template  DNA,  
C(HET)  refers  to  a  sample  from  an  already  known  Gulo  heterozygous  mouse.  M  =  100  
bp  DNA  ladder  (New  England  Biolabs  –  N3231S).  
  
  
Chop  locus  genotype  protocol  
  CHOP   Forward   primer   (common)   (5’–3’):   ATGCCCTTACCTATCGTG,   CHOP   wild   type  
reverse  primer  (5’-­‐3’):  GCAGGGTCAAGAGTAGTG  and  CHOP  KO  reverse  primer  (5’-­‐3’):  =  
AACGCCAGGGTTTTCCCAGTCA  were  added  to  the  multiplex  PCR  master  mix.  The  cycle  
as   follows:  94°C   for  2  minutes,  94°C   for  30   seconds,  61°C   for  30   seconds,  72°C   for  1  





     
102  
  
Figure   63   –   Representative   snapshot   of   an   agarose   gel   with   the   amplicons   of   the  
genotype  of  Chop  locus  of  5  different  pups.  “C-­‐”  refers  to  a  blank,  i.e.  a  sample  without  
template  DNA,  C(HET)  refers  to  a  known  Chop  heterozygous  mouse,  C(KO)  to  a  known  
Chop  KO  mouse  and  C(WT)  to  a  known  Chop  Wild-­‐type  mouse.  M  =  1  kbp  DNA  ladder  




SUnSET  protocol  for  quantification  of  new  proteins  
The   rate   of   protein   synthesis      in   the   gastrocnemius   and   diaphragm   of   mice   was  
analysed      by   using   the   in   vivo   “SUnSET”   technique   (Surface   Sensing   of   Translation)  
(Schmidt   et   al.,   2009).   Briefly,   mice   were   starved   for   30   min,   then   injected   in   the  
peritoneum  with  puromycin  (0.040  μmol/g),  a  drug  that  binds  the  nascent  polypeptide  
and   causes   premature   termination   of   the   translation.   After   30   minutes   from   the  
puromycin  injection  the  muscles  were  homogenized  with  a  Polytron  homogenizer  in  an  
ice-­‐cold  buffer  (40  mM  TRis,  pH7,5,  1mM  EDTA,  5mM  EGTA;  0,5%  Triton  X100  together  
to  protease  and  phosphatase  inhibitors).  Protein  concentrations  were  determined  with  
a  BCA  kit  and  the  amount  of  puromycin   incorporation   in  the  muscles  determined  by  
Immunoblot  with  a  mouse  anti-­‐puromycin  antibody  (Merck  Millipore).  
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Glucose  Tolerance  Test  (GTT)  
Mice   were   overnight   fasted.   The   day   after   the   basal   level   of   the   glycemia   was  
measured  from  a  blood  drop  from  the  tail  and  by  using  a  glucometer.  Then  mice  were  
intraperitoneally   injected   with   2   mg   of   glucose   for   each   gram   of   mouse   weight  
(Merck).  After  15,  30,  60,  120  and  180  minutes  from  the   injection  the  blood  glucose  
levels   were   recorded.   Mice   were   manipulated   in   an   isolated   room   by   the   same  
operator  to  reduce  the  risk  of  stress-­‐induced  altered  blood  glucose  levels.    
  
Glucose  uptake  measurements  
Cell  glucose  uptake  was  measured  using  a  radioactive  derivative  of  2-­‐deoxy-­‐D-­‐glucose  
radiolabeled   with   tritium   at   C1   and   C2.   This   is   a   glucose   analogue   unidirectionally  
transported  inside  the  cells  where  it’s  phosphorylated  and  remains  trapped  inside  the  
cells.  
C2C12  myotubes  were   serum   starved   for   1   h   then   incubated   in   Krebs-­‐Ringer   buffer  
(MgCl2:  0,0468  g/L,  KCl:  0,34  g/L,  Na2HPO4:0,1  g/L,  NaH2PO4:0,18  g/L)  with  0,3%  BSA  
and  with  0,5  μmol/L  2-­‐deoxy-­‐[3H]-­‐D-­‐glucose  (4  μci/mL)   for  30  min.  Later   insulin   (100  
nM)  was  added  to  the  cell  media  for  30  minutes.     Finally,  cell  medium  was  removed  
and   cells   were   rapidly   washed   with   cold   Krebs-­‐Ringer   buffer,   before   lysing   them   in  
0,2%  SDS.  Radioactivity  was  determined  by   liquid  scintillation  counting  (Perkin  Elmer  
2800   TR,   Courtaboeuf,   France)   and   protein   content   by   using   the   Bradford   protein  
assay.   Insulin-­‐dependent   glucose   uptake   was   determined   by   comparison   of   the  
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ASC  in  vivo  administration  
ASC  was  prepared  at  a  concentration  of  8,24  g/L  (with  sterile  water)  using  “L-­‐Ascorbic  
acid”  from  SIGMA  (A7506).  This  solution  was  then  diluted  to  0,33  g/L  (High-­‐dose),  0,11  
g/L   (Medium-­‐dose)   and   0,066   g/L   (Low-­‐dose)   to   which   EDTA   was   added   (at   a   final  
concentration   of   0,01   mM).   The   ASC   solution   was   added   to   the   drinking   bottles   in  
mouse  cages.  ASC  solution  was  changed  twice  a  week.        
  
HPLC  (High-­‐performance  liquid  chromatography)  for  ASC  content  in  cells  
ASC   in   the  cells  was  extracted  by  a   solution  of  60%  methanol  and  1  mM  EDTA   from  
which  the  precipitated  proteins  were  discarded  by  centrifugation  (10,600  g  for  5  min).    
ASC  was  analyzed  by  using  reverse-­‐phase  HPLC  with  a  Synergi  4  micron  Fusion-­‐RP  80  A  
column   (Phenomenex)   and   coulometric   detection.   The   chromatograph   consisted   of  
Shimadzu   LC-­‐10AD   pump   (Shimadzu,   Italy),   refrigerated   (4   °C)   717   autosampler  
(Waters,   Italy),   Coulochem   II   electrochemical   detector   equipped   with   a   5014B  
electrochemical  cell  consisting  of  two   in-­‐series  electrodes  (ESA,  Chelmsford,  MA)  and  
software   for   acquisition   and   calculation   of   chromatographic   data   (Azur   5.0;   Datalys,  
France).  Detector  settings  were  electrode  2.200  mV;  electrode  1.0  mV.  Mobile  phase  
contained  50  mM  sodium  phosphate  monobasic,  50  Mm  sodium  acetate  anhydrous,  
0.5  mM  acetyltrimethylammonium  bromide   dissolved   in  HPLC-­‐grade  water   (pH   4.8).  
Methanol  percentage  was  adjusted  to  20%  of  final  volume  and  the  mobile  phase  was  
filtered  through  0,  45  μ  m  membrane  filter  (Millipore)  and  degassed.  The  column  was  
conditioned  with  mobile  phase  at  1  mL/min  for  two  days  and  washed  after  every  30–
50  biological  samples  with  50%  methanol/  water  for  12  hours  at  1  mL/min.  Oxidation  
potentials  setting  for  the  electrochemical  cell  were  E1  0  mV;  E2  +  200  mV.  The  assay  
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was   calibrated   daily   with   fresh   solutions   (2.5–40   ng   of   standard   ASC)   diluted   in   the  
mobile  phase.  Retention  time  of  ASC  was  around  6.05  min.  
  
HPLC   (High-­‐performance   liquid   chromatography)   for   ASC   content   in   mice   skeletal  
muscles  
ASC  in  the  muscles  was  extracted  by  a  solution  composed  by  60%  methanol  and  1  mM  
EDTA  then  centrifuged  to  pellet  the  precipitated  protein  (10,600  g  for  5  min).    
The  column  of  4  mm  particle  size,  150  ×  4.6  mm,  Accucore  X  C18  (Thermo  Scientific,  
Italy)  was  coupled  with  a  drop-­‐in  10  ×  4.6  mm  guard  column  (Thermo  Scientific,  Italy).  
The  mobile  phase  was  prepared  by  dissolving  50  mM  NaH2PO4  and  50  mM  CH3COONa  
in  about  750  mL  ultrapure  water  (Milli-­‐Q;  Millipore,  Italy).  Two-­‐hundred  mL  methanol  
containing  0.5  mM  N-­‐cetyl-­‐N,N,N,  trymethylammonium  bromide  (CTMAB)  were  added  
to  the  buffer  solution,  the  pH  of  the  solution  adjusted  to  5.0  with  concentrated  H3PO4  
and   the   volume  brought   to   1   L  with   ultrapure  water.   After   filtration   (with   0.45  mm  
membrane  filters  (Sartorius  Stedim  Biotech,  Germany),  and  degassing  under  vacuum,  
the  mobile  phase  was  pumped  through  the  HPLC  system  at  a  constant  flow  rate  of  1  
mL/min.   The   column   and   guard   column   were   conditioned   with   mobile   phase   at   1  
mL/min  for  48  hours.  Oxidation  potentials  for  the  electrochemical  cell  were  set  at  E1  0  
mV;  E2  +  200  mV.  ASC  was  read  as  the  second  electrode  output  signal.  The  column  was  
calibrated   every   day  with   fresh   solutions   (2.5–40   ng   of   standard  ASC)   diluted   in   the  
mobile  phase.  Retention  time  of  ASC  was  3.20  min.  
  
Histological  analysis  of  muscles  
Muscles  were   flash-­‐frozen   in   isopentane   pre-­‐cooled   in   liquid   nitrogen,   embedded   in  
optimal  cutting  temperature  compound,  and  cross  sections  (8  µm  thick)  were  cut  with  
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a   cryostat.   Cryosections   were   processed   for   nicotinamide   adenine   dinucleotide-­‐TR  
(NADH-­‐TR)   staining,   hematoxylin   and   eosin   (H&E)   staining,   Oil   red-­‐O   (ORO)   staining  
and  periodic  acid-­‐Schiff  (PAS)  staining.    
NADH-­‐TR  staining  for  the  detection  of  type  I  myofibers  
Several   studies   show   that   type   I   myofibers   (oxidative)   have   a   higher   content   of  
oxidative   enzymes   such   as   succinate   dehydrogenase,   reduced   nicotinamide   adenine  
dinucleotide   tetrazolium   reductase   (NADH-­‐TR)   and   reduced   nicotinamide   adenine  
dinucleotide  phosphate-­‐tetrazolium  reductase  than  type  II  fibers  (glycolytic).  
NADH-­‐TR   is  a  staining  for  oxidative  fibers  and  therefore   leads  to  distinguish  between  
oxidative  and  glycolytic  fibers  in  sections  of  skeletal  muscle.  
Briefly,   muscle   sections   were   incubated   with   the   two   substrates   of   NADH-­‐TR,  
tetrazolium   and   NADH.   Tetrazolium   is   converted   to   a   purple-­‐blue   pigment   when   is  
reduced  by  accepting  electrons  from  NADH.  Therefore,  the  oxidative  fibers  with  a  high  
enzymatic   activity   will   be   stained   with   an   intense   blue/purple   color   whereas   the  
glycolytic  fibers  with  a  low  enzymatic  activity  with  a  paler  blue/purple  color.      
Practically,  fresh  cut  cross  sections  were  air  dried  for  15  minutes  and  incubated  with  a  
freshly-­‐    prepared  staining  solution  containing  TRIS-­‐HCL  0,1  M  pH  7.4,  25  mg  of  Nitro  
Blue   tetrazolium   (Sigma-­‐Aldrich,   N-­‐6876)   and   20   mg   of   β-­‐Nicotinamide   adenine  
dinucleotide  (Sigma-­‐Aldrich,  N-­‐8129)   for  40  minutes  at  37  °C.  Solutions  of  30,  60  and  
90  %  acetone  were  prepared  and  the  sections  were  rinsed  tree  times  in  each  of  these  
solutions  to  remove  the  unbound  tetrazolium.    Finally,  the  sections  were  rinsed  several  
times   in   deionized   H2O   and   mounted   with   the   aqueous   mounting   medium   onto   a  
labelled  glass  slide.    
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H&E  protocol  to  evaluate  the  morphology  of  the  fibers  
Hematoxylin   is   a   compound  with   positive   charge   that   binds   the   anionic   sites   of   the  
histones   in   the   chromatin,   hence   hematoxylin   stains   in   blue/violet   the   nuclei   of   the  
cells.  Eosin  binds  positively  charged  components  of  the  tissue,  such  as  cytoplasmic  and  
mitochondrial  proteins  and  the  extracellular  matrix,  resulting  in  a  pink  staining.  
Fresh  cut  cross  sections  of  muscles  were  air  dried  for  15  minutes  and  incubated  with  
Harris’  Hematoxylin   (Bio-­‐Optica,  05-­‐06004)   for  4  minutes,   rinsed  with   tap  water  and  
incubated   with   eosin   (Millipore   Merck,   1.15935.0025)   for   1   minute.   At   the   end,  
sections  were  washed  with   tap  water,   dehydrated  with   increasing   concentrations   of  
ethanol   (70-­‐80-­‐100%)   and   cleared   with   xylene.   Finally,   the   sections   were   mounted  
with  the  aqueous  mounting  medium  onto  a  labelled  glass  slide.    
Periodic  acid  Schiff  (PAS)  protocol  to  evaluate  glycogen  accumulation  
Periodic   acid   oxidizes   glycols   to   aldehydes,   then   Schiff   reagent   reacts   with   the  
aldehydes  giving  rise  to  a  purple-­‐magenta  color.  
Briefly,   fresh   cut   cross   sections   were   air   dried   for   15   minutes   and   fixed   with   10%  
formalin  for  10  minutes,  then  washed  with  distilled  H2O.  Sections  were  incubated  with  
0,5%  periodic  acid  (Sigma-­‐Aldrich,  P0430)  for  10  minutes  at  room  temperature,  rinsed  
in  distilled  water  then   incubated  with  Schiff   reagent   (Millipore  Merck,  1.09033.0500)  
for  15  minutes  at  room  temperature.  Finally,  sections  were  rinsed  with  distilled  water,  
dehydrated   with   increasing   concentration   of   ethanol   (70-­‐80-­‐100%),   cleared   with  
xylene  and  mounted  with  the  aqueous  mounting  medium  onto  a   labelled  glass  slide.  
Some   sections   were   pre-­‐incubated   with   amylase   (an   enzyme   that   digests  
polysaccharides)  to  validate  the  specificity  of  the  staining  in  recognizing  glycogen.  
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Oil-­‐Red  O  staining  protocol  to  stain  lipid  droplets  
Oil-­‐Red   O   is   a   fat-­‐soluble   dye   for   triglycerides   and   neutral   lipids   that   is   transported  
inside  cells  using  propylene  glycol.  Lipids  are  stained  with  a  red  color.  
Fresh  cut  12  µm  cross  sections  were  air  dried  for  30  minutes,  fixed  with  ice  cold  10%  
formalin   for   10   minutes   and   rinsed   with   distilled   water.   Once   completely   air   dried,  
sections  were  incubated  with  propylene  glycol  for  3  minutes  then  with  pre-­‐warmed  Oil  
Red   O   (Sigma-­‐Aldrich,   O0625)   solution   for   15  minutes   at   60°C.   Then,   sections  were  
incubated  with  85%  propylene  glycol  (Sigma-­‐Aldrich,  398039)  for  3  minutes  and  rinsed  
twice   in   distilled   water.      Finally,   sections   are   rinsed   in   Harris’   Hematoxylin   for   3  
minutes,   washed   with   distilled   water   and   mounted   with   a   non-­‐aqueous   mounting  
medium.  
For  immunofluorescence  analysis,  muscle  cryosections  were  incubated  with  a  solution  
of   PBS   containing   10%   bovine   serum   albumin   (BSA)   and   mounted   with   aqueous  
mounting   medium   (Fluorescence   Mounting   Medium,   Dako).   Muscle   section   were  
acquired  at  10X  by  Olympus  BX-­‐61  Virtual  Stage  microscope.  
The   fiber   size   diameter   (minimal   Feret’s   diameter)   was   determined   on   8   µm   frozen  
muscle   sections   stained   with   Alexa   Fluor   ®488   conjugate   of   wheat-­‐germ   agglutinin  
(WGA),   a   lectin   that   binds   sialic   acid   and   N-­‐acetyl-­‐glucosaminyl   residues   in   the  
connective  tissue.    
  
In  vivo  muscle  force  measurements  
In  vivo  muscle  force  was  measured  using  a  305B  muscle  lever  system  (Aurora  Scientific  
Inc.)  in  mice  anesthetized  with  a  mixture  of  Xylotine  and  Zoletil.  Mice  were  placed  on  a  
thermostatically  controlled  table,  the  knee  was  kept  stationary  and  the  foot  was  firmly  
fixed  to  a  footplate,  which  was  connected  to  the  shaft  of  the  motor.  Contraction  was  
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elicited  by  an  electrical  stimulation  of  the  sciatic  nerve.  Teflon-­‐coated  7  multistranded  
steel  wires  (AS  632,  Cooner  Sales,  Chatsworth,  CA,  U.S.A.)  were  implanted  with  sutures  
on  either  side  of  the  sciatic  nerve  close  to  the  knee.  At  the  distal  ends  of  the  two  wires  
the  insulation  was  removed,  while  the  proximal  ends  were  connected  to  a  stimulator  
(Grass  S88).   In  order   to  avoid   recruitment  of   the  dorsal   flexor  muscles,   the  common  
peroneal  nerve  was  cut.    
  
Ex  vivo  diaphragm  force  measurements  
Force  development  measurements  in  the  diaphragm  were  made  in  an  ex  vivo  setting.  
Small  strips  of  diaphragms  were  cut  and  mounted  between  a  force  transducer  and  a  
micro  manipulated  shaft,  in  an  oxygenated  organ  bath.  Optimal  length  was  determined  
through  the   length-­‐tension  curve  at  100  Hz  stimulation  frequency.  Tetanic   force  was  
determined  after  stimulation  with  trains  of  500  ms  once  every  two  seconds  at  100  Hz  
(Blaauw  et  al.,  2009).  
  
  Protein  lysate  from  muscles  
The  muscles   were   frozen   and   rapidly   pulverized   with   liquid   nitrogen.   The   obtained  
powder   was   mechanically   lysed   using   an   Ultra   Turrax   homogeniser   in   RIPA   buffer  
(except   for   SunSET).   The   insoluble   material   was   isolated   by   centrifugation   of   the  
samples   at   a   10.000   rpm   for   5   minutes.   The   protein   lysate   was   recovered   and  
quantified  using  the  BCA  method.    
  
Treadmill  
Mice   were   trained   on   an   open   treadmill   (TSE-­‐Systems   Phenomaster/Labmaster)   for  
two  days.  The  third  day  mice  started  to  run  at  a  speed  of  10  m/min  for  forty  minutes,  
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then  the  speed  was  increased  of  1  m/min  every  10  min  for  a  total  of  30  min  and  finally  
the  speed  was  increased  by  1  m/min  every  five  minutes  until  the  mice  were  exhausted.  
Exhaustion  was  defined  as  the  point  at  which  mice  spent  more  than  five  seconds  at  the  
start  of   the   lane  despite  air   stimulation   (provided  by  an  air  puff).   The  muscles  were  
isolated  five  hours  after  the  treadmill  running.  
  
Antibodies  
The  following  antibodies  were  used  for  Western  blotting:  monoclonal  mouse  anti-­‐beta  
Actin   from   Santa   Cruz,  mouse   anti-­‐GAPDH   from   Sigma,  mouse   anti-­‐puromycin   from  
Merck   Millipore,   mouse   anti-­‐   KDEL   (to   recognize   BIP)   from   Enzo   Life   Sciences   and  
polyclonal  rabbit  anti-­‐ERO1α.  The  following  antibodies  were  used  for  Immunostaining:  
monoclonal  BA-­‐D5  (to  stain  type1  fiber)  and  SC71-­‐S  D5  (to  stain  type  2  A  fiber)   from  
Iowa  Hybridoma  bank.  
  
High-­‐fat  diet  and  palmitate  treatment  
Male  WT   and   SEPN1  KO  mice  were   fed   a   regular   diet   or   a   high-­‐fat   diet   (HFD)   (MD.  
88137,  42%  from  fat  prepared  by  ENVIGO).  
C2C12   cells   were   incubated   with   palmitic   acid   (P0500   SIGMA),   that   was   previously  




Plasma   insulin   levels  were  measured  by  means  of  an  enzyme-­‐linked   immunosorbent  
assay  (ELISA)   (Abcam,  ab100578)  using  mouse   insulin  as  the  standard.  The  pancreata  
were   removed   and   immediately   frozen   in   liquid   nitrogen.   Protein   extracts   were  
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prepared   using   the   acid/ethanol   method.   The   protein   in   tissue   extracts   was  
determined  using  the  Bradford  method.  
  
C2C12,  SEPN1  knockdown  and  lentiviral  transduction  
C2C12  cells  were  cultured  in  DMEM  supplemented  with  25  mM  glucose  and  10%  foetal  
calf   serum   (FCS).   SEPN1   was   knocked   down   using   Mission™   shRNA-­‐encoding  
lentiviruses  against  mouse  SEPN1  mRNA  (SHCLND-­‐NM_029100.2,  Sigma)  following  the  
manufacturer's   instructions:   knockdown   pooled   KD   was   targeted   with   shRNA  
TRCN0000247860.   Mock   cells   were   obtained   by   means   of   a   lentivirus   driving  puro-­‐
resistance.  After  transduction  and  selection  with  puromycin  at  5  µg/ml  for  7  days,  the  
cells  were  used  for  ascorbate  measurements.  
  
SEPN1  KD  recombinant  adenovirus  and  acute  SEPN1  knock  down  in  C2C12  
The  SEPN1  shRNA  sequence   TRCN0000247860  was   sub-­‐cloned  under  a  U6  promoter  
together  a  GFP  under  a  CMV  promoter  in  an  adenoviral-­‐Type5  (dE1/E3)  backbone  and  
the  adenovirus  was  produced  by  Vector  BIOLABS   (Malvern,  PA,  USA)   (titer  2.7×1010  
PFU/mL).   Similarly,   a   GFP   adenovirus   (Ad-­‐CMV-­‐GFP,   titer   1×1010   PFU/mL)   was  
produced   as   a   control.   The   adenoviruses   were   used   at   200   multiplicity   of   infection  
(MOI)   to   infect   low   passages   C2C12   cells   at   a   50%   of   confluence   in   differentiation  
media  (DMEM  high  glucose,  5%  horse  serum).  After  3  days  in  differentiation  media  the  
cells  were  harvested  and  the  levels  of  SEPN1  were  analysed  by  Real-­‐Time  quantitative  
PCR.  After  additional  three  days  of  differentiation  (six  days  of  differentiation)  glucose  
uptake  was  assessed.    
  
  




Six  thousand  C2C12  cells/well  were  plated  in  96-­‐well  plates.  A  day  later,  the  media  was  
replaced  and  the  cells  incubated  with  complete  media  with  palmitate  (24  h).  Later  cells  
were   incubated   in   MTS   [3-­‐(4,5-­‐dimetiltiazolo-­‐2-­‐il)-­‐5-­‐(3-­‐carbossimetossifenil)-­‐2-­‐(4-­‐
solfofenil)-­‐2H-­‐tetrazolio]   and   PMS   (Phenazine  methosulfate)   as   indicated   in   CellTiter  
96®   Aqueous   Non-­‐Radioactive   Cell   Proliferation   Assay   (Promega).   Acquisitions   were  
made  by  TECAN  infinite  M200  using  excitation  wavelengths  at  490  nm.  
  
Real-­‐time  quantitative  RT-­‐PCR  analysis  
Total   RNA  was   isolated   from   the   cells   and  muscle   tissue   using   the   RNeasy  Mini   Kit  
(Qiagen).  One  microgram  of  total  RNA  was  reverse-­‐transcribed  and  analysed  using  the  
Applied   Biosystems'   real-­‐time   PCR   System   and   the   ΔΔCt   method.   Relative   gene  
expression   in   cells   was   normalized   to   beta-­‐actin   or   cyclophilin,   and   relative   gene  
expression  in  muscle  was  normalized  to  cyclophilin  or  GAPDH  mRNA  levels.  
The  real-­‐time  primers  were:  
mGADD34  F:  GAGGGACGCCCACAACTTC  R:  TTACCAGAGACAGGGGTAGGT  
mCHOP  F:  CCACCACACCTGAAAGCAGAA  R:  AGGTGAAAGGCAGGGACTCA  
mBIP  F:  TCATCGGACGCACTTGGAA  R:  CAACCACCTTGAATGGCAAGA  
mATF4  F:  ATGGCCGGCTATGGATGAT  R:  CGAAGTCAAACTCTTTCAGATCCATT  
mERO1  F:  CATACTCAGCATCGGGGGAC  R:  GAATGTGAGCAAGCTGAGCG  
mSEPN1  F:  GCTTTCCTGTAGAGATGATG  R:GCCCCGCCGGAGTCCTTC  
mXBP1s  F:  GAGTCCGCAGCAGGTG  R:  GTGTCAGAGTCCATGGGA  
mXBP1  total  F:  GGAGTGGAGTAAGGCTGGTG  R:  CCAGAATGCCCAAAGGATA  
  
  




All  results  were  analysed  using  Prism  5  and  6  software  (Graphpad).  N  was  indicated  in  
the  figure  legend  except  for  dot  plots.  One  asterisk  was  used  for  p  <  0.05,  two  for  p  <  
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